Respirology

Previous issue Volume 23 Supplement Issue s2
November 2018
Next issue
Special Issue: 23rd Congress of the Asian Pacific Society of Respirology, 29 November–2 December 2018, Taipei, Taiwan
Index Submit
an article
About
Respirology
Read this
issue's articles
TUBERCULOSIS 1
5ASSOCIATION BETWEEN NUTRITIONAL STATUS USING MALNUTRITION SCREENING TOOL AND BACTERIAL LOAD AMONG MDR-TB PATIENTS
5PHARMACOVIGILANCE FOR PUBLIC HEALTH UTILITY: SAFETY MONITORING OF NEW REGIMEN FOR LATENT TUBERCULOSIS INFECTION TREATMENT
5PUBLIC-PRIVATE MIX ACTIVITIES IN ENHANCING TUBERCULOSIS CASE NOTIFICATIONS IN SURABAYA, INDONESIA
6GENEXPERT MTB/RIF FOR RAPID DIAGNOSIS AND RIFAMPIN RESISTANCE DETECTION OF ENDOBRONCHIAL TUBERCULOSIS
6EFFICACY AND SAFETY OF DELAMANID FOR PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS
6POLY-FUNCTIONAL CD8 T CELLS CAN DISCRIMINATE MAC LUNG DISEASE FROM AIRWAY COLONIZATION IN NON-HIV HOST
6RARE EXTRAPULMONARY TUBERCULOSIS: FOUR CASES REPORT
7QUANTIFERON-TB GOLD PLUS IS MORE SENSITIVE THAN QUANTIFERON-TB GOLD IN-TUBE FOR LATENT TUBERCULOSIS INFECTION AMONG RESIDENTS IN LONG-TERM CARE FACILITY
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 1
7CHANGES IN VENTILATION AND PERFUSION FOLLOWING LOWER LOBE ENDOSCOPIC LUNG VOLUME REDUCTION (ELVR) WITH ENDOBRONCHIAL VALVES IN PATIENTS WITH SEVERE COPD
8ANALYSIS OF 35 CASES OF BRONCHIAL FISTULA CURED BY IMPLANTATION OF NITINOL DOUBLE DRUM TYPE OCCLUDER
8UTILITY AND SAFETY OF COBALT CHROMIUM NEEDLE FOR ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (EBUS-TBNA)
8USEFULNESS OF TRANSESOPHAGEAL BRONCHOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION IN THE DIAGNOSIS OF MEDIASTINAL LESIONS ADJACENT TO THE OESOPHAGUS
9IS BRONCHOSCOPY INDICATED IN PATIENTS WITH HAEMOPTYSIS WHEN THE CT IS NORMAL?
9FEASIBILITY AND CLINICAL IMPACT OF RE-BIOPSY IN ADVANCED LUNG ADENOCARCINOMA AFTER PROGRESSES DURING FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS
9THE ROLE OF CT-GUIDED PERCUTANEOUS TRANSTHORACIC NEEDLE BIOPSY WITH VIETNAM BIOPSY CALIBRATOR FOR THE DIAGNOSIS OF PULMONARY NODULES
COPD 1
10LINKING AIRWAY GENE EXPRESSION AND LUNG MICROBIOME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
10INVESTIGATING MICRORNA-MRNA INTERACTIONS IN THE COPD MICROENVIRONMENT BY NEXT-GENERATION SEQUENCING AND BIOINFORMATICS
11THE EFFECT AND RELATED MECHANISM OF PHOSPHODIESTERASE 4 (PDE4) INHIBITOR ON CD4+ T LYMPHOCYTE PROLIFERATION
11THE ROLE OF MIR-21/SMAD7/TGF-β PATHWAY IN COPD AND THE INFLUENCE ONACTIVATION OF TH17 CELL
11DECREASED LEVELS OF PTEN, A NEGATIVE REGULATOR OF PHOSPHOINOSITIDE 3-KINASE (PI3K)/AKT PATHWAY, ARE CORRELATED WITH OBSTRUCTIVE IMPAIRMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
12OBSERVATION OF THE EFFECT OF METERED DOSE INHALERS AND ELECTRICAL IMPEDANCE TOMOGRAPHY PATTERNS ON MECHANICALLY VENTILATED PATIENTS WITH ACUTE EXACERBATION OF OBSTRUCTIVE PULMONARY DISEASES
12SMALL MOLECULE C ENHANCES CELLULAR METABOLISM VIA CREB SIGNALLING IN EXPERIMENTAL MODELS OF COPD
12CHANGES OF NEW EPIGENETIC MODIFICATIONS IN THE LUNGS OF CIGARETTE SMOKE EXTRACT-INDUCED MURINE EMPHYSEMA MODEL
13PATTERN OF SPUTUM CULTURE IN ADULT PATIENTS WITH BRONCHIECTASIS IN THE TOP END OF AUSTRALIA
CLINICAL RESPIRATORY MEDICINE 1
13ENDOTHELIN-1 INDUCES MESOTHELIAL MESENCHYMAL TRANSITION AND CORRELATES WITH PLEURAL FIBROSIS IN TUBERCULOUS PLEURAL EFFUSIONS
13THE CORRELATION BETWEEN SMOKING STATUS AND URINARY COTININE LEVEL WITH FEF25–75% IN HIGH SCHOOL STUDENTS
14IMPLEMENTATION OF COLLABORATIVE NURSING INTERVENTIONS AND POINTING AND CALLING FOR CHECKING AND DELIVERING VENTILATION PARAMETERS OF INVASIVE MECHANICAL VENTILATOR
14ADDITIONAL ROLE OF BRONCHIAL MUCOSAL BIOPSY FOR CILIARY STRUCTURAL ABNORMALITY IN DIAGNOSIS OF PRIMARY CILIARY DYSKINESIA
14EFFECT OF ORAL CHLORHEXIDINE IN PREVENTING HOSPITAL-ACQUIRED PNEUMONIA AMONG NON-INTUBATED PATIENTS IN THE PHILIPPINES
15THE USE OF MEDICAL RESEARCH COUNCIL (MRC) DYSPNOEA GRADE IN PREDICTING PEAK OXYGEN UPTAKE AND WORK RATE IN UNDIFFERENTIATED DYSPNOEA.
15PULMONARY REHABILITATION IN JAPAN: A POSITION STATEMENT FROM THE JSRCR/JSRPT/JRS
RESPIRATORY STRUCTURE AND FUNCTION
16CHRONIC INHALATION OF UNFLAVORED NICOTINE AND NO-NICOTINE CONTAINING ELECTRONIC CIGARETTE VAPOR LEADS TO IMPAIRED LUNG FUNCTION
16ASTROCYTIC ACTIVATION IS NECESSARY FOR HYPOXIC RESPIRATORY FACILITATION
16RETROSPECTIVE ANALYSIS OF FIVE YEARS ON SINGLE CENTER PULMONARY FUNCTION TEST
17COMPARATIVE ANALYSIS OF PFT AND 3D LOW DOSE CHEST CT BASED LUNG VOLUME ASSESSMENTS IN SCOLIOSIS PATIENTS BEFORE AND AFTER SURGICAL CORRECTION
17INTER-OPERATOR VARIABILITIES OF AIRWAY INDICES IN MDCT IMAGES OF COPD PATIENTS
17SPIROMETER VALIDATION USING A FLOW/VOLUME SIMULATOR
18QUANTITATIVE ASSESSMENT OF AIRWAY STRUCTURE USING ULTRA-HIGH RESOLUTION COMPUTED TOMOGRAPHY
18THE VALUE OF RESPIRATORY BIPHASIC PULSE OSCILLATION INDEX IN DIFFERENTIAL DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA AND THE DIAGNOSIS OF EMPHYSEMA
LUNG CANCER 1
19FUNCTIONAL ANALYSIS OF MOB1 IN RESECTABLE LUNG ADENOCARCINOMA
19FROM IMMUNOSURVEILLANCE TO IMMUNOEDITING: THE ROLE OF IMMUNOBIOLOGY IN EARLY LUNG CANCER DETECTION
19GENETIC VARIANTS IN THE C-MYB SIGNALING PATHWAY GENES PREDICT SURVIVAL OF NON-SMALL CELL LUNG CANCER PATIENTS IN THE PLCO CANCER SCREENING TRIAL
20NSCLC PATIENTS WITH BOTH WILDTYPE EGFR AND HIGH CD151 EXPRESSION HAVE POORER DISEASE OUTCOME
20FACTORS PREDICTING THE EFFICACY OF OSIMERTINIB IN T790M-MUTATED METASTATIC LUNG ADENOCARCINOMA
20THE CLINICAL ANALYSIS OF PULMONARY LYMPHOEPITHELIOMA-LIKE CARCINOMA WITH EPITHELIOID GRANULOMA: FOURTEEN CASES AND LITERATURE REVIEW
21GEMCITABINE ENHANCES ANTI-TUMOR ACTIVITY OF PACLITAXEL BY MODULATING TUBULIN ACETYLATION
21THE REAL-WORLD EFFICACY OF FIRST-LINE TYROSINE KINASE INHIBITORS IN ASIAN PATIENTS WITH EGFR MUTATION NON-SMALL CELL LUNG CANCER
22MICRO RNA-21 TARGETING PI3K/PTEN/AKT SIGNALING AXIS REGULATES MULTIPLE BIOLOGICAL FUNCTIONS IN HUMAN LUNG CANCER
CRITICAL CARE MEDICINE 1
22INTENSIVE CARE UNIT ADMISSION AND SURVIVAL IN STAGE IV CANCER PATIENTS WITH SEPTIC SHOCK: A POPULATION-BASED COHORT STUDY
23NETS PROMOTES ALI/ARDS INFLAMMATION BY REGULATING ALVEOLAR MACROPHAGES POLARIZATION
23A PREDICTIVE VALUE OF TRYPTOPHANYL-TRNA SYNTHETASE ON THE MORTALITY IN INTENSIVE CARE UNIT PATIENTS
23ADD ON AZITHROMYCIN: REDUCE NOSOCOMIAL INFECTIONS AND VENTILATOR ASSOCIATED PNEUMONIA IN CRITICAL PEDIATRIC CARDIOVASCULAR SURGERY PATIENTS
24PIRFENIDONE AMELIORATES LIPOPOLYSACCHARIDE-INDUCED PULMONARYINFLAMMATION AND FIBROSIS BY BLOCKING NLRP3 INFLAMMASOME ACTIVATION
24INDUCED PLURIPOTENT STEM CELLS ATTENUATE ENDOTOXIN-INDUCED ACUTE LUNG INJURY VIA TREM-1 EXPRESSION TO REDUCE P38/IKB PATHWAY ACTIVITY
24POINT-OF-CARE ULTRASOUND: A NEW CHOICE OF EARLY QUANTITATIVE DIAGNOSE OF PULMONARY EDEMA
25EFFECTS OF ACID FIBROBLAST GROWTH FACTOR ON LIPOPOLYSACCHARIDES-INDUCED ACUTE LUNG INJURY IN RAT
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 1
25EMPIRIC VANCOMYCIN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA (CAP): INCREASING USE IN USA FROM 2007 TO 2015 AND POSSIBLE STRATEGY FOR DEESCALATION
26PREDICTORS OF DEVELOPING MYCOBACTERIUM KANSASII PULMONARY INFECTION WITHIN 1 YEAR AMONG PATIENTS WITH SINGLE ISOLATION IN MULTIPLE SPUTUM SAMPLES
26THE FIRST CASE OF COMMUNITY-ACQUIRED PRIMARY AND MULTIPLE LUNG ABSCESS DUE TO SEROTYPE K2 HYPERVIRULENT KLEBSIELLA PNEUMONIAE IN ADULT; AN EXTREMELY RARE CLINICAL COURSE
27ANTIBIOTICS SUSCEPTIBILITY AND TREATMENT OUTCOMES OF MYCOBACTERIUM CHIMAERA PULMONARY DISEASE – A RETROSPECTIVE STUDY
27NEXT GENERATION SEQUENCING ASSISTED PATHOGENIC DETECTION CAN IMPROVE OUTCOMES IN IMMUNOCOMPROMISED HOST WITH PULMONARY INFECTION
28PROGNOSTIC VALUES OF CURB-65, EXPANDED-CURB-65, AND CURB-65 PLUS ALBUMIN AND PLATELET IN COMMUNITY ACQUIRED PNEUMONIA IN CIPTO MANGUNKUSUMO NATIONAL GENERAL HOSPITAL, JAKARTA
ASTHMA 1
28DEVELOPMENT OF THE SEVERE ASTHMA TOOLKIT: A CLINICAL WEBSITE RESOURCE FOR THE MANAGEMENT OF SEVERE TREATMENT-REFRACTORY ASTHMA
29ESTABLISHMENT OF EOSINOPHILIC BRONCHITIS MOUSE MODEL WITH NONINVASIVE LUNG FUNCTION TEST
29IMPACT OF FRACTIONAL EXHALED NITRIC OXIDE MEASUREMENT ON MANAGEMENT OF PATIENTS WITH SUSPECTED ASTHMA
29REDUCED NUCLEAR FACTOR-KB REPRESSING FACTOR AND INCREASED INTERLEUKIN-8 IN BRONCHIAL EPITHELIAL CELLS IN ASTHMA
30THE EFFECTIVENESS OF MEPOLIZUMAB IN 19 PATIENTS WITH SEVERE ASTHMA IN JAPAN
30METABONOMICS OF ALLERGIC ASTHMA: POTENTIAL BIOMARKERS HETES AND THEIR METABOLIC KEY ENZYME GPX
31ANTI-REMODELLING FEATURES OF ARTESUNATE AS A POTENTIAL NOVEL DRUG FOR THE TREATMENT OF ASTHMA
31THE PREVALENCE AND CLINICAL CHARACTERISTICS OF T2-LOW AND T2-HIGH ENDOTYPE OF SEVERE UNCONTROLLED ASTHMA DISTINGUISHED BY COMBINING TYPE-2 BIOMARKERS
31MULTIDIMENSIONAL GAPS IN HEALTH CARE FACILITIES FOR ASTHMA PATIENTS IN INDONESIA; A FORMATIVE RESEARCH
ENVIRONMENTAL & OCCUPATIONAL HEALTH AND EPIDEMIOLOGY
32MESENCHYMAL STEM CELL-BASED THERAPY ATTENUATES SILICA-INDUCED MACROPHAGE ACTIVATION VIA CIRCZC3H4/ZC3H4 PATHWAY
32LONG-TERM EXPOSURES TO AIR POLLUTANTS AND RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACES), A NATIONWIDE 10-YEAR OPEN COHORT STUDY IN TAIWAN
33THE ROLE OF SIRTUIN1 IN THE MACROPHAGE POLARIZATION INDUCED DIRECTLY BY AIRBORNE PM2.5
33FINDING A HIDDEN ASBESTOS RELATED LUNG CANCER: MULTI-CENTERED ACTIVE SURVEILLANCE SYSTEM IN KOREA
33HYPERCAPNIC ACIDOSIS ATTENUATES DECOMPRESSION SICKNESS-INDUCED LUNG INJURY
34ASSOCIATION OF PHYSICAL ACTIVITY WITH LUNG FUNCTION IN DUSTY AREAS COHORT
34LUTEOLIN DECREASES THE PM2.5-INDUCED AUTOPHAGY OF MH-S BY SCAVENGING ROS
INTERSTITIAL LUNG DISEASE 1
35NINTEDANIB AND PIRFENIDONE INHIBIT LYSOPHOSPHATIDIC ACID-INDUCED VASCULAR ENDOTHELIAL GROWTH FACTOR AND COLLAGEN PRODUCTION IN HUMAN PRIMARY LUNG FIBROBLASTS
35THE LONG TERM STUDY OF SIROLIMUS IN CHINESE POPULATION WITH LYMPHANGIOLEIOMYOMATOSIS
3510 YEARS-EXPERIENCE OF USING PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS
36PULMONARY ALVEOLAR PROTEINOSIS IN KOREA: ANALYSIS OF PREVALENCE AND INCIDENCE BY A NATIONWIDE POPULATION-BASED STUDY
36THE PULMONARY MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX IN TAIWANESE PATIENTS
37MORPHOLOGICAL ANALYSIS OF ALVEOLAR MACROPHAGE IN PATIENTS WITH SARCOIDOSIS: LET'S REFLECT THE CELL ON A BRONCHOALVEOLAR FLUID SPECIMEN-PART 2.
37EXOSOMES-DERIVED FROM MACROPHAGES TREATED WITH ANGII PROMOTE LUNG FIBROSIS VIA ACTIVATING TGF-B/SMAD2/3 PATHWAY BY SHIFTING RAS TO ACE/ANGII/AT1R AXIS
RESPIRATORY NEUROBIOLOGY AND SLEEP
37CPAP PRESSURE IS ASSOCIATED WITH EFFECT OF MANDIBULAR ADVANCEMENT DEVICE FOR TREATING TREATMENT-NAÏVE PATIENTS WITH OSA
38RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNOEA, OTHER CARDIOVASCULAR RISK FACTORS AND CARDIOVASCULAR DISEASE
38NON-APNOEA SLEEP DISORDER INCREASES THE RISK OF INCIDENT HEART FAILURE-A NATIONWIDE POPULATION-BASED COHORT STUDY
39DOES CHRONIC INTERMITTENT HYPOXIA ALWAYS INCREASE BLOOD GLUCOSE LEVELS IN MICE?
39DECREASED MIR-21-5P AND MIR-23-3P EXPRESSIONS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: A POTENTIAL PROTECTIVE EFFECT BY REGULATING TNF-ALPHA SIGNALING
40PRENATAL CHRONIC INTERMITTENT HYPOXIA LEADS TO EARLY ATHEROSCLEROTIC LESIONS AND UPREGULATES CAVEOLIN-1 EXPRESSION IN RATS
40UPPER AIRWAY IMAGING DURING A NOVEL INTRA-ORAL NEGATIVE PRESSURE DEVICE THERAPY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
CLINICAL RESPIRATORY MEDICINE 2
41AUTOMATED ALERTING AND DECISION SUPPORT FOR REPORTING OF PHYSIOLOGIC DETERIORATION VIA A CLINICAL ALERTING SYSTEM IN PATIENTS WITH PNEUMONIA ADMITTED TO THE GENERAL WARDS
41FIRST SUCCESSFUL CASE OF CHEMICAL PLEURODESIS WITH OXYTETRACYCLINE THROUGH ROCKET® PLEURAL VENT™ - AMBULATORY PNEUMOTHORAX DEVICE FOR PNEUMOTHORAX
42SOUND-SPECTROGRAM WILL BE USEFUL IN THE DIFFERENTIAL DIAGNOSIS OF WHEEZES: BRONCHOSPASM OR FIXED AIRWAYS NARROWING?
42CLINICAL CHARACTERISTICS OF CHRONIC COUGH: ADULT CHRONIC COUGH COHORT STUDY OF Republic of Korea
43A COMPARATIVE STUDY ON THE DIAPHRAGM MUSCLE THICKNESS AND RAPID SHALLOW BREATHING INDEX (RSBI) AS A PREDICTOR FOR SUCCESSFUL EXTUBATION AMONG CRITICALLY ILL ADULT PATIENTS
43QUALITY CHANGES OF CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY DISEASES IN CHINA: A SYSTEMATIC APPRAISAL
44CLINICAL PATHWAY AND DURATION OF HOSPITALIZATION IN PATIENTS WITH ACUTE EXACERBATION OF BRONCHIECTASIS
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 2
44THE PROGNOSTIC PREDICTORS OF PATIENTS WITH AIRWAY INVOLVEMENT DUE TO ADVANCED OESOPHAGEAL CANCER AFTER METALLIC AIRWAY STENTING USING FLEXIBLE BRONCHOSCOPY
44A MULTICENTRE, PROSPECTIVE TRIAL OF ELECTROMAGNETIC BRONCHOSCOPIC AND ELECTROMAGNETIC TRANSTHORACIC NAVIGATIONAL APPROACHES FOR THE BIOPSY OF PERIPHERAL PULMONARY NODULES (ALL IN ONE)
45CRYOBIOPSY – A POTENTIAL TO BREAK THROUGH THE DIAGNOSTIC BRONCHOSCOPY FOR PERIPHERAL PULMONARY NODULES -
45EVALUATION OF TRANSBRONCHIAL LUNG CRYOBIOPSY FREEZING TIME, CRYOBIOPSY SIZE, HISTOLOGICAL QUALITY AND INCIDENCE OF COMPLICATION: A PROSPECTIVE CLINICAL TRIAL
45FEASIBILITY AND SAFETY OF CRYOBIOPSY IN INTERVENTIONAL BRONCHOSCOPY
46EFFICACY AND SAFETY OF ARGON PLASMA COAGULATION (APC) PLUS PARTIALLY SPRAYED ADHESIVE VIA THORACOSCOPY IN THE TREATMENT OF SPONTANEOUS PNEUMOTHORAX PATIENTS WITH SUBPLEURAL BLEBS DISEASES
COPD 2
46EARLY MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
46THERAPEUTIC TARGETING OF THE IL-6 TRANS-SIGNALLING IN PULMONARY EMPHYSEMA
47MMP-12 ACTIVATES PROTEASE ACTIVATED RECEPTOR (PAR)-1, UPREGULATES PLACENTA GROWTH FACTOR AND LEADS TO PULMONARY EMPHYSEMA
47THE PROTECTIVE ROLE OF BRONCHIAL EPITHELIAL CELLS DERIVED EXOSOME IN COPD
48ANDROGRAPHOLIDE SIMULTANEOUSLY AUGMENTS NRF2 ANTIOXIDANT DEFENSE AND FACILITATE AUTOPHAGIC FLUX BLOCKADE IN CIGARETTE SMOKE-EXPOSED HUMAN BRONCHIAL EPITHELIAL CELLS
48PRMT6 MEDIATES INFLAMMATION VIA THE ACTIVATION OF NF-KB/P65 PATHWAY ON CIGARETTE SMOKE EXTRACT-INDUCED MURINE EMPHYSEMA MODEL
48THE INFLAMMATORY CYTOKINE ENVIRONMENT OF COPD ALTERS THE AIRWAY EPITHELIAL RESPONSES TO VIRAL AND BACTERIAL STIMULI
49CCL-1/CCL-2 INHIBITION BY ROLIPRAM IN MONOCYTES OF COPD
49SODIUM TANSHINONE IIA SULFONATE INHIBITS CIGARETTE SMOKE-INDUCED INFLAMMATION AND OXIDATIVE STRESS IN MICE VIA INHIBITING AKT/HIF-1α SIGNALING PATHWAY
PAEDIATRIC LUNG DISEASE
49POST-OPERATIVE OUTCOME OF PAEDIATRIC EMPYEMA TREATED WITH VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS)
50COMMUNITY-ACQUIRED NECROTIZING PNEUMONIA DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SECRETING PANTON-VALENTINE LEUKOCIDIN IN 4 PATIENTS ADMITTED TO CHILDREN'S HOSPITAL 1 IN NOVEMBER 2017: CASE SERIES REPORT
50CHANGES AFTER AUTOMATED CONTROL OF INSPIRED OXYGEN CONCENTRATION IN PRETERM INFANT WHO UNDERWENT CPAP
50SPONTANEOUS PNEUMOMEDIASTINUM WITH SUBCUTANEOUS EMPHYSEMA IN AN 8 YEAR OLD FEMALE: A CASE REPORT
51DIAGNOSTIC VALUE OF SALIVARY LIQUEFIED CARBOHYDRATE ANTIGEN KL-6 IN CHILDREN WITH PNEUMONIA
51PNEUMONIA DUE TO BURKHOLDERIA PSEUDOMALLEI IN CHILDREN AT THE CHILDREN'S HOSPITAL NO 1, HOCHIMINH-CITY, VIET NAM
51PRIMARY CILIARY DYSKINESIA IN JAPAN
52UTILITY OF FRACTIONAL EXHALED NITRIC OXIDE (FENO) LEVELS IN DIFFERENTIATINGUPPER RESPIRATORY TRACT INFECTION AND BRONCHIAL ASTHMA FROM HEALTHY NORMAL SCHOOL CHILDREN
CRITICAL CARE MEDICINE 2
52PATHOGEN IDENTIFICATION WAS NOT ASSOCIATED WITH MORTALITY IN PATIENTS ADMITTED TO A MEDICAL INTENSIVE CARE UNIT WITH PNEUMONIA
53PREDICTORS OF OUTCOME AMONG LUNG TRANSPLANTATION PATIENTS SUPPORTED WITH EXTRACORPOREAL MEMBRANE OXYGENATION
53SEROTONIN AND VASCULAR PERMEABILITY (SEROTONIN BEYOND THE BRAIN) --- ANALYSIS OF SEROTONIN IN SEPSIS AND ARDS
53PROTECTION EFFECT OF OVERWEIGHT AND OBESITY IN CRITICALLY ILL ADULT PATIENTS WITH INFLUENZA: A MULTICENTER RETROSPECTIVE COHORT STUDY IN TAIWAN
54HIGH TIDAL VOLUME MECHANICAL VENTILATION REDUCES RESPIRATORY CENTER DRIVE BY POTASSIUM CHANNELS ALTERATION
54UTILITY OF 6-MIN WALK TEST IN PREDICTING POST-OPERATIVE PULMONARY COMPLICATIONS AMONG PATIENTS UNDERGOING CARDIOTHORACIC SURGERIES
55KINETICS OF OXYGEN UPTAKE DURING THE SPONTANEOUS BREATHING TRIAL PREDICTS WEANING OUTCOMES FOR PATIENTS WITH PROLONGED MECHANICAL VENTILATION: A PROSPECTIVE ANALYSIS AT A WEANING UNIT
55NEUTROPHIL EXTRACELLULAR TRAPS AUGMENTED ALVEOLAR MACROPHAGES PYROPTOSIS IN LPS INDUCED ALI/ARDS
PULMONARY CIRCULATION
55CLINICAL COURSE AND OUTCOMES OF PATIENTS WITH SUBMASSIVE PULMONARY EMBOLISM
56PREVALENCE OF VENOUS THROMBOEMBOLISM AMONG ADULT PATIENTS DIAGNOSED WITH CANCER AT ST. LUKE'S MEDICAL CENTER FROM 2010-2015
56FACTORS RELATED TO PULMONARY HYPERTENSION IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
57TRENDS IN HOSPITALIZATION AND MORTALITY OF VENOUS THROMBOEMBOLISM FROM 2007 TO 2016 IN CHINA
ASTHMA 2
57ALTERED AIRWAY TRANSCRIPTOMICS AFTER BRONCHIAL THERMOPLASTY TREATMENT IN SEVERE ASTHMATICS
57CORRELATION BETWEEN FUNGAL ALLERGEN EXTRACTS AND COMPONENTS OF ASPERGILLUS FUMIGATUS SIGE SENSITIZATION IN PATIENTS WITH RESPIRATORY TRACT ALLERGIC DISEASES IN SOUTHERN CHINA
58SHORT TERM EFFICACY OF BENRALIZUMAB FOR SEVERE ASTHMATIC PATIENTS IN JAPAN
58EFFECTIVENESS OF ASTHMA EDUCATION FOR NURSES USING AN ASTHMA CARE APPLICATION COMPARED TO A WRITTEN ASTHMA ACTION PLAN IN THAILAND
58THE CLINICAL AND PATHOPHYSIOLOGICAL FEATURES OF COUGH-PREDOMINANT-ASTHMA
59HIGH FRACTIONAL EXHALED NITRIC OXIDE LEVELS PREDICT SHORT-TERM WORSENING OF RESPIRATORY RESISTANCE
59CAN FASTER ESCALATIONS IMPROVE THE EFFECTIVENESS OF ASTHMA ACTION PLANS?
59THE CHARACTERISTICS OF SERUM HYDROXY-EICOSATETRAENOIC ACIDS IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
60VIETNAM HEALTHY LUNG PROGRAM – A SOLUTION TO FULFIL THE GAPS IN ASTHMA AND COPD MANAGEMENT
TUBERCULOSIS 2
60LYMPHOCYTE LEVELS ASSOCIATION WITH BACTERIAL LOAD AND PULMONARY LESION FORM IN MDR TB PATIENT
60THE ADHERENCE AND ADVERSE EFFECT OF USING PREVENTIVE THERAPY FOR LATENT TUBERCULOSIS THERAPY AMONG KIDNEY TRANSPLANT CANDIDATES
61TREND OF MULTIDRUG-RESISTANT TUBERCULOSIS OVER 20 YEARS: DRUG RESISTANCE, TREATMENT OUTCOMES, AND ADVERSE EVENTS
61INITIAL IMPLEMENTATION OF SHORTER REGIMEN FOR MDR-TB IN DR SOETOMO HOSPITAL, SURABAYA: THE PROPORTION BETWEEN ELIGIBILITY AND INELIGIBILITY
61CHYLOUS EMPYEMA AND SECONDARY SPONTANEOUS PNEUMOTHORAX COMPLICATING PULMONARY TUBERCULOSIS
62LUNG CANCER AND TUBERCULOSIS: COMPLEXITIES IN DIAGNOSIS AND MANAGEMENT
62RESISTANCE PATTERN AMONG DRUG-RESISTANT TUBERCULOSIS PATIENTS IN INDONESIA
63SEVEN DAYS OF FLUOROQUINOLONE EXPOSURE PRIOR TO TUBERCULOSIS DIAGNOSIS IS ASSOCIATED WITH AN INCREASED RISK OF MORTALITY
CELL AND MOLECULAR BIOLOGY
63IMMUNOLOCALIZATION OF ZINC TRANSPORTERS AND METALLOTHIONEINS SUPPORTS A POTENTIAL ROLE OF ZINC IN ENDOTHELIUM-SMOOTH MUSCLE CROSS TALK IN VASCULAR PHYSIOLOGY AND COPD
63MITOFUSINS IN TYPE 2 ALVEOLAR CELLS ARE REQUIRED FOR METABOLIC ADAPTATION IN PULMONARY FIBROSIS
64NEW INSIGHTS OF THE PATHOLOGY OF PULMONARY FIBROSIS REVEALED BY METABOLOME ANALYSIS ~ANTI-FIBROTIC FACTOR STANNIOCALCIN1 (STC1) AND SYSTEMIC DAMAGE RESPONSE~
64EXPERIMENTAL LUNG INJURY REDUCES KRÜPPEL-LIKE FACTOR 2 TO INCREASE ENDOTHELIAL PERMEABILITY VIA REGULATION OF RAPGEF3-RAC1 SIGNALING
64TREATMENT WITH TRICHOSTATIN A RESTORES SENSITIVITY TO GEFITINIB AND IMPAIRS CANCER STEM CELLS FEATURES IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER CELLS
65REGULATIONAL MECHANISM OF CELL MOTILITY AND GM-CSF SECRETION BY P116RIP VIA MYOSIN AND CREB PHOSPHORYLATION IN HUMAN LUNG FIBROBLASTS
65A NOVEL PEPTIDE WKYMVM HAS THERAPEUTIC EFFECT VIA IRF7/STAT1 PATHWAY AGAINST ENDOTOXIN-INDUCED ARDS
65BIOLOGICAL EFFECTS OF PRETERM BIRTH ON AIRWAY DEVELOPMENT
66THE EFFECT OF OBESITY ON THE EXPRESSION OF α7 NICOTINIC ACETYLCHOLINE RECEPTOR IN LPS-INDUCED LUNG INFLAMMATION
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2
66CLINICAL CHARACTERISTICS OF COMMUNITY-ACQUIRED PNEUMONIA DUE TO MORAXELLA CATARRHALIS IN ADULTS: A RETROSPECTIVE SINGLE CENTER STUDY
66RELATIONSHIP BETWEEN INITIAL ANTIBIOTIC THERAPY AND OUTCOMES IN HOSPITALIZED PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA AT DR SOETOMO GENERAL HOSPITAL, SURABAYA
67IN VITRO ANTIMICROBIAL SUSCEPTIBILITY AND TREATMENT OUTCOMES OF MOLECULAR DIAGNOSED MYCOBACTERIUM KANSASII PULMONARY DISEASE
67OVERCOMING BIOFILM MEDIATED RESPIRATORY INFECTIONS THROUGH EXPLOITATION OF PATHOGEN AND HOST-DIRECTED NOVEL PEPTIDES
68APPLICATION OF TRANSMISSION ELECTRON MICROSCOPY IN THE ETIOLOGIY DIAGNOSIS OF SEVERE PNEUMONIA VIA BALF: A RETROSPECTIVE STUDY
68SERUM IGA ANTIBODIES AGAINST GLYCOPEPTIDOLIPID CORE ANTIGEN WITH SMOOTH OR ROUGH MORPHOTYPES IN PATIENTS WITH MYCOBACTERIUM ABSCESSUS COMPLEX LUNG DISEASE
68THE CORRELATION ANALYSIS BETWEEN VIRUS LOADING AND SHEDDING WITH THE CLINICAL FEATURE OF PATIENTS INFECTED BY INFLUENZA VIRUS IN ADULT
LUNG CANCER 2
69TAIWAN LUNG CANCER SCREENING PROGRAM FOR NEVER SMOKERS
69CLINICAL IMPLICATION OF DNA METHYLATION ANALYSIS IN THE ORAL EPITHELIUM FOR LUNG CANCER RISK STRATIFICATION
70METABOLIC PROFILING CLASSIFIES NON-SMALL CELL LUNG CANCER CELLS INTO DIFFERENT SUBTYPES WITH DISTINCT SENSITIVITIES TO METABOLIC INHIBITIONS
70ANGIOTENSIN-(1-7) SUPPRESSES NSCLC ACQUIRED PLATINUM RESISTANCE-INDUCED TUMOR ANGIOGENESIS VIA PI3K/AKT AND MAPK SIGNALING PATHWAYS
70THE ROLE OF THE GROUND-GLASS OPACITY RATIO IN RESECTED LUNG ADENOCARCINOMA
71DIFFERENTIAL C-TERMINAL PROTEIN FRAGMENTS OF α-1-MICROGLOBULIN/BIKUNIN PRECURSOR AS POTENTIAL MAKER FOR EARLY DETECTION OF LUNG ADENOCARCINOMA
71PHOSPHORYLATION OF THE CYTOSKELETAL PROTEIN CAP1 REGULATES NON-SMALL CELL LUNG CANCER SURVIVAL AND PROLIFERATION BY GSK3β
71EPIGENETIC THERAPY MODULATES POLYFUNCTIONALITY OF TUMOR-REACTIVE T CELLS IN NON-SMALL CELL LUNG CANCER
72PROGRESSION-FREE SURVIVAL AMONG PROGRESSED NON-SMALL CELL LUNG CANCER (NSCLC) WITH T790M MUTATION AS GUIDED BY LIQUID BIOPSY IS SHORTER THAN THOSE BASED ON TISSUE RE-BIOPSY
TUBERCULOSIS 3
72ADVERSE REACTIONS AMONG PATIENTS BEING TREATED WITH SHORTER MULTI-DRUG RESISTANT TUBERCULOSIS REGIMEN AT PERSAHABATAN HOSPITAL, INDONESIA
73THE MYELOID DERIVED SUPPRESSOR CELLS INCREASED PREDOMINANTLY IN LATENT TUBERCULOSIS INFECTION WHILE REGULATORY T CELLS ELEVATED IN TB REACTIVATION
73HOW EFFECTIVE IS THE SYSTEMIC INTEGRATION OF SMOKING CESSATION INTO TUBERCULOSIS CONTROL PROGRAMME IN CREATING SMOKE-FREE ENVIRONMENTS IN THE PHILIPPINES?
74CORRELATION BETWEEN CLINICAL MANIFESTATION AND SEVERITY OF TUBERCULOSIS DISEASE (A MULTI-CENTRE STUDY IN INDONESIA)
74ENDOBRONCHIAL LESION IN PATIENTS WITH SMEAR-NEGATIVE PULMONARY TUBERCULOSIS
74PROLONGED QT AND TORSADE DE POINTES IN PATIENT WITH XDR TUBERCULOSIS TREATED WITH BEDAQUILLINE
75CD8 RESPONSE MEASURED BY QUANTIFERON-TB GOLD PLUS AND TUBERCULOSIS DISEASE STATUS
75A RARE ENTITY: DISSEMINATED TUBERCULOSIS WITH EVANS SYNDROME
CLINICAL ALLERGY AND IMMUNOLOGY
75AN EVIDENCE-BASED MEDICINE FOLLOW-UP AND COMPARISON STUDY ON ATOPIC UPPER AND LOWER AIRWAY DISORDER
75INCREASED NUMBERS OF GROUP 2 INNATE LYMPHOID CELLS IN THE AIRWAYS OF PATIENTS WITH EOSINOPHILIC BRONCHITIS
76ASIA-PACIFIC SURVEY OF PHYSICIANS ON ASTHMA AND ALLERGIC RHINITIS (ASPAIR): DATA FOR GENERAL PRACTITIONERS COMPARED TO PAEDIATRICIANS
76INCREASED NUMBERS OF CD4+CRTH2+ T CELLS IN THE AIRWAYS OF PATIENTS WITH EOSINOPHILIC BRONCHITIS
INTERSTITIAL LUNG DISEASE 2
77IMPAIRMENT OF LUNG DIFFUSE FUNCTION IN PATIENTS WITH PULMONARY LYMPHANGIOMYOMATOSIS (LAM)
77LONG-TERM TREATMENT WITH NINTEDANIB IN ASIAN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: RESULTS FROM INPULSIS-ON
78NON-INTERVENTIONAL STUDY COLLECTING EXPERIENCES FOR IPF IN TAIWAN (NICEFIT STUDY): INTERIM REPORT
78EFFECT OF TOCILIZUMAB ON INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
78DOES FEF25–75 DISTINGUISH BETWEEN AIRWAY OBSTRUCTION AND RESTRICTION IN DPLD?
79CIGARETTE SMOKING CAN AGGRAVATE PULMONARY FIBROSIS BY INDUCING ALVEOLAR EPITHELIAL CELL II SENESCENCE
COPD 3
79HEART RATE VARIABILITIES BIOFEEDBACK AS AN ADJUNCT TO PULMONARY REHABILITATIVE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
80FACTORS ASSOCIATED WITH NON-ATTENDANCE TO PULMONARY REHABILITATION IN CANTERBURY, NEW ZEALAND
80IMPACT OF MUSIC THERAPY ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS
81EFFICACY AND SAFETY OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE METERED DOSE INHALER (GFF MDI) DELIVERED USING CO-SUSPENSION DELIVERY TECHNOLOGY IN CHINESE PATIENTS WITH COPD
81BENEFITS AND RISKS OF INHALED CORTICOSTEROID TREATMENT IN PATIENTS WITH COPD CLASSIFIED BY BLOOD EOSINOPHIL COUNTS
82CLINICAL COURSE OF COPD PATIENTS WITH BOTH EMPHYSEMA AND AIRWAY WALL THICKENING ON CT COMPARED TO OTHER PHENOTYPES
82FOUR-WEEKS REMOTE PULMONARY REHABILITATION PROTOCOL WITH MOBILE APPS OF REAL-TIME HEART RATE MONITORING FOR GOLD CATEGORY B/C/D- A STUDY DESIGN
LUNG CANCER 3
83IMMUNOLOGICAL ANALYSIS OF PLEURAL EFFUSION IN CANCER PATIENTS WHO RECEIVED IMMUNE CHECKPOINT INHIBITORS (ICI) FOR THE DEVELOPMENT OF BIOMARKERS
83STUDY OF SYNERGISTIC EFFECT OF METFORMIN WITH PEMETREXED IN LUNG CANCER THERAPY VIA ORTHOTOPIC LUNG INJECTION FLUORESCENT MICE TUMOR MODEL
83ADENYLATE CYCLASE-ASSOCIATED PROTEIN 1-TARGETED NANOPARTICLES AS A NOVEL STRATEGY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER
84INCIDENCE OF BRAIN METASTASIS IN PATIENT WITH NEWLY DIAGNOSED LUNG ADENOCARCINOMA
84ASSOCIATION BETWEEN LIQUID BIOPSY AND TISSUE BIOPSY FOR EGFR MUTATION IN LUNG ADENOCARCINOMA
85MIR-126* AND MIR-145 AS POTENTIAL BIOMARKERS FOR NON-SMALL CELL LUNG CANCER
85MIR-204 RESTORES THE EGFR TYROSINE KINASE INHIBITOR-SENSITIVITY THROUGH ATTENUATING EPITHELIAL TO MESENCHYMAL TRANSITION AND CANCER STEMNESS
85EVALUATION OF THE EFFICACY AND SAFETY OF INTRAPLEURAL INJECTION OF BEVACIZUMAB TREATMENT OF MALIGNANT PLEURAL EFFUSION CAUSED BY LUNG ADENOCARCINOMA
AWARD SESSION
86CLINICAL SIGNIFICANCE OF ASPERGILLUS SPECIES ISOLATED FROM RESPIRATORY SPECIMENS IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE
86COMBINATION THERAPY WITH NINTEDANIB AND PREDNISOLONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
87A QUALITATIVE STUDY EXPLORING THE BARRIERS AND CHALLENGES TO ASTHMA MANAGEMENT AS PERCEIVED BY MALAYSIAN ASTHMATIC PATIENTS
87EVALUATION OF UPPER AIRWAY (UA) ANTHROPOMETRY USING MAGNETIC RESONANCE IMAGING (MRI) AND LATERAL CEPHALOMETRY IN PATIENTS OF OBSTRUCTIVE SLEEP APNEA (OSA) IN NORTH INDIAN POPULATION.
87IDENTIFICATION OF A NEW TARGET FOR DIAGNOSING IDIOPATHIC PULMONARY FIBROSIS WITH AUTOIMMUNE FEATURES
88ENDOSOMAL NOX2 OXIDASE INHIBITOR PROTECTS AGAINST HIGHLY PATHOGENIC INFLUENZA VIRUS MORBIDITY
88EPIGENETIC REGULATION OF FZD9 AND ILOPROST LUNG CANCER CHEMOPREVENTION
88A MULTI-LEVEL APPROACH TO ASTHMA HEALTH DISPARITIES: FROM BIOMARKERS TO GEOCODED DATA
PULMONARY CIRCULATION
89PULMONARY HYPERTENSION IN CPFE (COMBINED PULMONARY FIBROSIS AND EMPHYSEMA)
ASTHMA 1
90CHANGES IN FRACTIONAL NITRIC OXIDE CONCENTRATION IN EXHALED BREATH WITH THE USE OF ICS/LABA INHALERS
90FEF25–75 IS THE BETTER DIAGNOSTIC TOOL FOR IDENTIFYING ASTHMA PATIENTS
90HEALTHY LUNG ASIA INITIATIVE
91ANCA NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: 4 CASES REPORT AND LITERATURE REVIEW
91COMMON MICRORNA CHANGES IN BRONCHIAL EPITHELIAL CELLS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES
91S1P/S1PR3 PATHWAY HAS THE ROLE IN EOSINOPHILIC AIRWAY INFLAMMATION VIA RELEASE OF CCL20 FROM BRONCHIAL EPITHELIAL CELLS
91ALLERGIC SENSITIZATION PROFILE OF POLYSENSITIZED ASTHMATIC PATIENTS IN SOUTHERN CHINA USING MOLECULE-BASED IGE TECHNIQUE
92PREDICTORS TO THE EXACERBATION OF BRONCHIAL ASTHMA AMONG CHILDREN BETWEEN 6–18 YEARS OLD AT CHONG HUA HOSPITAL
92POST HOC ANALYSIS OF INITIAL TREATMENTS AND CONTROL STATUS USING DIFFERENT GINA CRITERIA IN INITIAL, AN OBSERVATIONAL STUDY OF NEWLY DIAGNOSED CHINESE PATIENTS WITH ASTHMA
93SMALL AIRWAY DYSFUNCTION PREDICTED FIXED AIRFLOW OBSTRUCTION IN OLDER ASTHMA PATIENTS
93CHITIN INDUCED PRODUCTION OF PROSTAGLANDIN E2 IN ALVEOLAR MACROPHAGES AND BRONCHIAL EPITHELIAL CELLS
93THE LEVEL OF PLASMINOGEN ACTIVATOR INHIBITORS 1 IN ASTHMA PATIENTS AND CORRELATION WITH LUNG FUNCTION AND DEGREE OF ASTHMA CONTROL
94CORELATION BETWEEN INHALED BETA-2 AGONIST AND CORTICOSTEROID WITH THE DEGREE OF ASTHMA CONTROL AND LUNG FUCTION
94THE ROLE OF APS F 6 THE COMPONENT OF ASPERGILLUS FUMIGATUS ON THE IDENTIFYING ABPA AND ASTHMA
94ASSOCIATION OF PSORIASIS WITH ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
95PERCEPTION OF DOCTORS ABOUT DIAGNOSIS, MANAGEMENT AND FACING THE CHALLENGES WITH THEIR PATIENTS WITH ASTHMA: AN OBSERVATION-BASED SURVEY IN NEPAL
95ROUTINE BENZODIAZEPINE USE MAY NOT INCREASE THE FREQUENCY OF ASTHMA EXACERBATIONS
96THE EFFECT OF USING MOBILE APP FOR TRAINING NURSES ON CORRECT USE OF INHALER DEVICES
96A SURVEY ON THE MORBIDITY AND COST OF MULTIPLE CHRONIC CONDITIONS IN ASTHMA PATIENTS
96DIFFERENT IMPACTS OF COMORBIDITY OF ALLERGIC RHINITIS ON OBESE AND NON-OBESE PATIENTS WITH ASTHMA
97INHIBITION OF MAB ON PROLIFERATION AND MIGRATION OF ASMCS INDUCED BY PDGF-BB AND ITS EFFECTS ON MITOCHONDRIA
97RETROSPECTIVE STUDY TOTAL SERUM IMMUNOGLOBULIN E, ALLERGEN-SPECIFIC IGE PROFILE AND PERIPHERAL BLOOD EOSINOPHILIA PERCENTAGE IN MODERATE TO SEVERE ASTHMATIC PATIENTS IN RESPIRATORY CLINIC, TAIPING HOSPITAL
97RESPONSE OF GOBLET CELLS OF BRONCHIAL EPITHELIUM IN PATIENTS WITH MILD ASTHMA AND COLD AIRWAY HYPERRESPONSIVENESS TO REGULAR CONTROLLER THERAPY WITH INHALED CORTICOSTEROIDS
98HEALTHY LUNG PROGRAMME: AN INITIATIVE FROM TSPCCM (TAIWAN SOCIETY OF PULMONARY AND CRITICAL CARE MEDICINE) AND ASTRAZENECA (AZ) TAIWAN TO IMPROVE TAIWAN ASTHMA MANAGEMENT
98THE RATIO OF NEURAL DRIVE TO TIDAL VOLUME MEASURED FROM SURFACE ELECTRODES CAN DETECT CLINICALLY SIGNIFICANT FALLS IN FEV1 IN ASTHMATIC SUBJECTS DURING HISTAMINE CHALLENGE
98RISK FACTORS AND MECHANISM FOR ANXIETY AND DEPRESSION IN CHINESE ADULTS WITH ASTHMA
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 1
99USING GUIDING DEVICE AS ASSISTED TOOL WITH ENDOBRONCHIAL ULTRASOUND TRANSBRONCHIAL BIOPSY TO GET ADEQUATE REBIOPSY SAMPLE
99RADIAL PROBE ENDOBRONCHIAL ULTRASOUND ASSISTED CONVENTIONAL TRANSBRONCHIAL NEEDLE ASPIRATION IN THE DIAGNOSIS OF SOLITARY PERIBRONCHIAL PULMONARY LESION LOCATED IN THE SEGMENTAL BRONCHI
100A NOVEL METHOD FOR TREATING THE REFRACTORY AND SEVERE BENIGN CENTRAL AIRWAY STENOSIS WITH OSCILLATING POSITIVE EXPIRATORY PRESSURE: TWO CASES REPORT
100A CASE OF BRONCHIAL FOREIGN BODY ASPIRATION CAUSED BY JAPANESE SPINY LOBSTER'S ANTENNA
100A CASE OF BRONCHIAL MUCOEPIDERMOID CARCINOMA TREATED BY PHOTODYNAMIC THERAPY
101DOES BRONCHOSCOPY HAVE A RISK OF POSTOPERATIVE RECURRENCE?
101FACTORS INFLUENCE THE DIAGNOSTIC YIELD OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL BIOPSY IN PERIPHERAL PULMONARY LESIONS
102SAFETY EVALUATION OF RIGID BRONCHOSCOPIES AND THE RAPEUTIC PROCEDURES
102USE OF CRYOBIOPSY DURING SEMI-RIGID PLEUROSCOPY
103ENDOBRONCHIAL BALLOON TAMPONADE ACHIEVING SUCCESSFUL CONTROL OF MASSIVE HAEMOPTYSIS SECONDARY TO METASTATIC LUNG DISEASE: A CASE REPORT
103EVALUATION THE PHYSIOLOGICAL CHANGES OF CENTRAL AIRWAY ON MULTI-DETECTOR COMPUTED TOMOGRAPHY
103INITIAL EXPERIENCE ON PERCUTANEOUS CATHETER DRAINAGE FOR RESPIRATORY DISEASES IN SRI LANKA: AN AUDIT
104A CASE OF RIGHT LUNG REEXPANSION DUE TO TRACHEAL PERFORATION
104THE IMPACT OF THE HIGH-FLOW NASAL OXYGEN TO THE SAFETY AND SEDATIVE QUALITY OF PATIENTS UNDERGOING BRONCHOSCOPY- PRELIMINARY DATA
105A SIMPLIFIED METHOD OF TRANSESOPHAGEAL NEEDLE ASPIRATION WITH AN ULTRASOUND-GUIDED BRONCHOSCOPE (EBUS-TENA)
105MOLECULAR ANALYSIS OF SMALL TISSUE SAMPLES OBTAINED VIA TRANSBRONCHIAL LUNG BIOPSY USING RADIAL PROBE ENDOBRONCHIAL ULTRASOUND
105IS UNIPORTAL VIDEO-ASSISTED THORACOSCOPIC SURGERY ACCEPTABLE AS A STANDARD SURGICAL TECHNIQUE FOR THE PRIMARY SPONTANEOUS PNEUMOTHORAX?
106CASE STUTY DOUBLE STENTING OF OESOPHAGUS AND AIRWAY IN PALLIATIVE TREATMENT OF PATIENT WITH OESOPHAGEAL CANCER
106FLEXIBLE BRONCHOSCOPE INTERVENTIONAL THERAPY UNDER MECHANICAL VENTILATION FOR SEVERE AIRWAY STENOSIS: CASE REPORTS
106RECURRENT PNEUMOTHORAX IN SJOGREN SYNDROME
107SUGAR FROSTING-LIKE LESION IS A HINT OF MESOTHELIAL HYPERPLASIA UNDER PLEUROSCOPY: A CASE REPORT
107BRONCHIAL OCCLUSION WITH ENDOBRONCHIAL WATANABE SPIGOT FOR HAEMOPTYSIS IN A MECHANICALLY VENTILATED PATIENT WITH EXTRACORPOREAL CIRCULATION
107FEASIBILITY AND SAFETY OF FLEXIBLE BRONCHOSCOPY-GUIDED MICROWAVE ABLATION IN PORCINE LUNG: A NEW IMAGE-GUIDED MICRO-INVASIVE ABLATION METHOD FOR LUNG LESIONS
108IMPROVED HOSPITALISATION STAY WITH INDWELLING PLEURAL CATHETER
108MANAGEMENT OF EARLY AIRWAY RESTENOSIS AFTER THE PLACEMENT OF METAL COVERED STENT: A CASE REPORT
CELL AND MOLECULAR BIOLOGY 1
109THE ASSOCIATION OF VANADIUM PENTOXIDE AND INFLAMMATORY RESPONSE IN PATIENTS WITH COPD AND IN HUMAN BRONCHIAL EPITHELIAL CELL
109GENETIC ASSOCIATION OF RS2227589 POLYMORPHISM WITH PULMONARY EMBOLISM RISK IN CHINESE POPULATION
109MITOCHONDRIAL MEMBRANE POTENTIAL IN CHILDRENWITH INTERSTITIAL LUNG DISEASES (ILD)
110INHIBITION OF NEUTROPHIL ELASTASE CONTRIBUTES TO ATTENUATION OF LIPOPOLYSACCHARIDE INDUCED ACUTE LUNG INJURY DURING NEUTROPENIA RECOVERY IN MICE
110DUAL BRONCHODILATOR SUPPRESSES CIGARETTE SMOKE EXTRACT-INDUCED AUTOPHAGIC CELL DEATH IN HUMAN BRONCHIAL EPITHELIAL CELLS
110SPECIFIC SPHINGOSINE KINASE 1 INHIBITOR, SK1-I ATTENUATES NEUTROPHIL ELASTASE INDUCED AIRWAY INFLAMMATION AND GOBLET CELL HYPERPLASIA IN MICE
111TILIROSIDE CAN MODULATE UPPER AIRWAY SECRETION BY THE INHIBITION OF CALCIUM ACTIVATED CL- CHANNEL, ANO1
111REGULATORY MECHANISMS OF SYSTEMIC INFLAMMATION IN RESPIRATORY PATHOLOGY
111POLARIZATION OF ALVEOLAR MACROPHAGE IN MODEL OF DIET INDUCED OBESE MICE WITH VENTILATOR INDUCED LUNG INJURY
112DEVELOPMENT OF A METHOD TO PREDICT THE PERSISTENT PULMONARY INFLAMMATION BY NANOPARTICLES AT AN EARLY STAGE WITH GENE EXPRESSION LEVEL
112DICHLOROACETATE, AN INHIBITOR OF AEROBIC GLYCOLYSIS, AMELIORATES NEUTROPHILIC AIRWAY INFLAMMATION THROUGH SUPPRESSING TH17 POPULATION AND INDUCING REGULATORY T CELL POPULATION
CLINICAL ALLERGY AND IMMUNOLOGY 1
112PREVALENCE AND CLINICAL CHARACTERISTICS OF AIRWAY DISEASES IN PATIENTS WITH ULCERATIVE COLITIS
113ANALYSIS OF ADVERSE REACTIONS AND RISK FACTORS TO SCIT IN CHILDREN WITH ALLERGIC
113ASIA-PACIFIC SURVEY OF PHYSICIANS ON ASTHMA AND ALLERGIC RHINITIS (ASPAIR): DATA FOR THREE HYPOTHETICAL CASE STUDIES
114UNCONTROLLED BRONCHIAL ASTHMA: A RARE CASE OF CHURG-STRAUSS SYNDROME
114ANALYSIS OF DISTRIBUTION CHARACTERISTICS OF TIGE AND SIGE IN PATIENTS WITH RESPIRATORY ALLERGIC DISEASES
114MAPPING MIMOTOPES FOR HOUSE DUST MITE ALLERGEN DER F 7 USING A SPECIFIC MONOCLONAL ANTIBODY
CLINICAL RESPIRATORY MEDICINE 1
115THYMOMA (WORLD HEALTH ORGANIZATION TYPE B3) WITH NEUROENDOCRINE DIFFERENTIATION: A RARE TYPE OF THYMOMA
115PNEUMOCONIOSIS FOLLOWING CHRONIC CHARCOAL DUST EXPOSURE: DESCRIPTION OF A RARE ASSOCIATION AND A CASE PRESENTATION
115QUANTIFYING MYELOID-DERIVED SUPPRESSOR CELLS IN PLEURAL EFFUSION CAN DISTINGUISH TUBERCULOSIS FROM PNEUMONIA
116SAFETY OF PRE-OPERATIVE PULMONARY FUNCTION TESTING IN LEFT MAIN CORONARY ARTERY DISEASE
116APPLICATION OF NOCTURNAL OXYGEN THERAPY/BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) TO TREAT PATIENTS WITH CHRONIC LUNG DISEASE AND NOCTURNAL OXYGEN DESATURATION WHO REQUIRED HOSPITALIZATION
116A CASE OF EMPYEMA CAUSED BY ESOPHAGOPLEURAL FISTULA SUCCESSFULLY TREATED WITH SELF-EXPANDABLE METALLIC STENT
117INFECTED BULLOUS LUNG DISEASE
117SKIN DEEP: A CASE OF DERMATOMYOSITIS INITIALLY PRESENTING WITH PLEURAL EFFUSION
117LONG UVULA: AN UNUSUAL CAUSE OF CHRONIC COUGH IN AN ADULT
118PLEURA-CONTACT SIGN FOR PREDICTING INDETERMINATE LUNG NODULES IN PATIENTS WITHOUT CANCER HISTORY
118A RARE CASE OF ADOLESCENT IDIOPATHIC SCOLIOSIS WITH RIGHT LUNG AGENESIS IN A 16 YEAR OLD FEMALE
119A CASE OF PULMONARY LANGERHANS CELL HISTIOCYTOSIS DEVELOPED AFTER COMPLETED ANTI-TUBERCULOSIS TREATMENT
119COMPARISON OF TWO NONINVASIVE DEVICES FOR MEASURING RESPIRATORY RATES WITHOUT A FACEMASK DURING WALKING
119NUTRITIONAL STATUS ASSESSMENT OF PULMONARY OUTPATIENTS OF UNIVERSITY OF SANTO TOMAS HOSPITAL
120EFFICACY AND SAFETY OF GLUCOCORTICOIDS IN THE TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA: A META - ANALYSIS
120PULMONARY ANGIOSARCOMA MIMICKING PULMONARY EMBOLISM - A CASE REPORT
120USE OF ACE INHIBITOR AND RISK OF POST-STROKE PNEUMONIA: EVIDENCE-BASED STUDY
COPD 1
121LIFE SPACE ACTIVITY IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
121A HOME-BASED APPROACH TO BETTER BREATHING IN CANTERBURY - A PILOT STUDY
121POTENTIAL THERAPEUTIC STRATEGY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING PIOGLITAZONE AUGMENTED-WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS
122ASSOCIATION BETWEEN SELF-MANAGEMENT BEHAVIOURS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE TYPES OF HEALTHCARE SERVICES: CROSS-SECTIONAL QUESTIONNAIRE STUDY
122DIAPHRAGMATIC CONTRACTION DURING HIGH-INTENSITY INSPIRATORY MUSCLE TRAINING IN COPD PATIENTS
122CHRONIC KIDNEY DISEASE LEADS TO ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS USING INHALED LONG-ACTING BRONCHODILATORS
123A STUDY OF THE DETECTION OF ORAL BACTERIA IN COPD PATIENTS
123THE TREND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON INTENSIVE CARE UNIT ADMISSION FROM 2003 TO 2013 IN TAIWAN
123CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH THORACIC CAGE REDUCTION UPON MOVEMENT LEADING TO LOW BACK PAIN AND LUMBER HYPEREXTENSION
124IDENTIFICATION OF KEY MODULES AND HUB GENES OF COPD PHENOTYPES WITH WEIGHTED GENE COEXPRESSION NETWORK ANALYSIS
124BACTERIAL COLONIZATION DID NOT AFFECT THE DECLINE OF PULMONARY FUNCTION AMONG BRONCHIECTASIS PATIENTS
124LOW SOCIOECONOMIC STATUS AND INCIDENCE OF AIRWAY OBSTRUCTION IN KOREA:A COMMUNITY-BASED COHORT STUDY
125PATIENTS WITH PULMONARY INFECTIONS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RETROSPECTIVE CLINICAL STUDY OF 170 CASES
125ACUPUNCTURE THERAPY FOR ACUTE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A LITERATURE ANALYSIS OF CLINICAL STUDY
125PRODUCTION OF REACTIVE PERSULFIDE SPECIES IN LUNGS OF PATIENTS WITH COPD AND THEIR EFFECTS ON LUNG-RESIDENT CELLS
126SERIAL CHANGES IN EXERCISE CAPACITY, QUALITY OF LIFE AND CARDIOPULMONARY RESPONSES AFTER PULMONARY REHABILITATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
126PDPI VERSION OF COPD SCREENING QUESTIONNAIRE VALIDITY AS A SCREENING TOOLS
127EFFICACY AND SAFETY OF HIGH-DOSE BUDESONIDE/FORMOTEROL (320/9 MG) IN PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME AFTER ALLOGENEIC HSCT
127EFFECT OF DAI-KENCHU-TO ON COPD EXACERBATIONS IN ELDERLY PATIENTS: A RETROSPECTIVE STUDY USING A NATIONWIDE DATABASE IN JAPAN
127CORRELATION BETWEEN RESPIRATORY CAPACITY, BODY MASS INDEX, SIX-MINUTES WALKING TEST, RESTING HEART RATE AND SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
128SAM PROTECTS AGAINST AUTOIMMUNE EMPHYSEMA OF RATS
128RISK FACTORS FOR THE ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
128PROGNOSTIC UTILITY OF THE DECAF SCORE TO PREDICT IN-HOSPITAL MORTALITY AMONG PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ADMITTED AT CHINESE GENERAL HOSPITAL
129QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON CLINICAL PHENOTYPES
129BUFEI YISHEN GRANULES SUPPRESS ALVEOLAR EPITHELIAL APOPTOSIS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE RATS: VIA PERK/ EIF2α SIGNALING
130A NEW PARALLEL TWO-STEP ALGORITHM FOR THE TREATMENT OF COPD
130EFFECTIVENESS OF PHARMACEUTICAL CARE ON THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ATTENDING A COMMUNITY HOSPITAL IN THAILAND
130EFFECTIVENESS OF A PULMONARY REHABILITATION PROGRAM IN A REHABILITATION HOSPITAL DAY CENTRE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS FROM PRIMARY CARE CLINICS
131NO2 INHALATION CAUSES IMPAIRED PULMONARY FUNCTION AND HAEMATOLOGICAL DERANGEMENT IN RATS AND INTERVENTION STUDY
131ENVIRONMENTAL FACTORS AND COPD IN THE DEVELOPMENT OF LUNG CANCER
131THE SNP RS61758360 LOCI REDUCING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
132GLYCOPYRROLATE IN HIGH-RISK COPD, A DRUG UTILIZATION SURVEILLANCE STUDY IN INDIA (GOAAL): POST-HOC ANALYSES
132STUDY ON THE EFFECTS OF PULMONARY REHABILITATION EXERCISE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN STABLE PERIOD
132COMPOSITE INDEX FOR RECENT MORTALITY IN COPD PATIENTS
133ASSOCIATION OF VITAMIN D3 WITH LUNG FUNCTION AND EXERCISE TOLERANCE IN STABLE COPD PATIENTS: A CROSS-SECTIONAL STUDY
133EFFICACY AND SAFETY OF ONCE-DAILY INHALED UMECLIDINIUM IN ASIAN PATIENTS WITH COPD: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED STUDY
133INVESTIGATION OF FRACTIONAL EXHALED NITRIC OXIDE LEVELS IN THE DIFFERENTIATION OF ASTHMA, COPD AND ASTHMA-COPD OVERLAP
134ANTI-INTERLEUKIN 5 AGENTS IN THE TREATMENT OF EOSINOPHILIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A SYSTEMATIC REVIEW AND META-ANALYSIS
134PULMONARY EMPHYSEMA AND LIPID DYSFUNCTION IN MICE LACKING FATTY ACID SYNTHASE IN ALVEOLAR EPITHELIAL CELLS
134A STUDY ON THE PERCEPTION AND REAL WORLD DATA ABOUT LONG TERM OXYGEN THERAPY IN PATIENTS WITH CHRONIC LUNG DISEASES IN KOREA
135METFORMIN USE REVERSES THE ADVERSE PROGNOSTIC EFFECT OF DIABETES MELLITUS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
135PRELIMINARY APPLICATION OF INTELLIGENT WRISTBANDS IN COPD PATIENTS
136EFFICACY AND SAFETY OF SWITCH FROM TIOTROPIUM TO INDACATEROL/GLYCOPYRRONIUM IN SYMPTOMATIC MILD-TO-MODERATE COPD PATIENTS FROM KOREA: A RANDOMIZED, OPEN-LABEL, 12-WEEK TRIAL
136NOVEL BENZOXAZIN DERIVATIVE AS NEUTROPHIL ELASTASE INHIBITOR FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
136APPRAISAL VALUE OF PERIPHERAL BLOOD EOSINOPHILS IN THE PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
137ANALYZING PATIENTS' CHARACTERISTICS ASSOCIATED WITH SLEEP DISTURBANCE IN COPD PATIENTS
137A PREDICTION MODEL FOR HOSPITALIZED COPD EXACERBATIONS BASED ON "TREATABLE TRAITS"
1372 MINUTE WALK TEST AS A SCREENING TOOL FOR COPD
CRITICAL CARE MEDICINE 1
138RARE PRESENTATION OF ACUTE B-LYMPHOBLASTIC LEUKAEMIA MIMICS GUILLAIN-BARRE SYNDROME: A CASE REPORT
138PREVENTION AND TREATMENT OF EARLY COMPLICATIONS AFTER DCD LUNG TRANSPLANTATION: A CASE SERIES
139DERIVATION OF WEANSNOW SCORE TO ASSESS THE PROBABILITY OF SUCCESSFUL EXTUBATION AND VENTILATOR LIBERATION: AN ANALYSIS AT THE INTENSIVE CARE UNIT OF A MEDICAL CENTER
139RISK OF RECURRENT RESPIRATORY FAILURE SUBSEQUENT TO SUCCESSFUL WEANING FROM INVASIVE MECHANICAL VENTILATION INITIATED FOR NON-SURGICAL REASONS: A NATIONWIDE COHORT STUDY
139LONG-TERM OUTCOME OF VERY ELDERLY (≥80 YEARS) CRITICAL-ILL PATIENTS IN MEDICAL INTENSIVE CARE UNIT IN A TERTIARY HOSPITAL OF KOREA
140LONG-TERM OUTCOME OF SURVIVORS WITH SEPSIS AFTER INTENSIVE CARE
140DELAYED ADMISSION TO ICU OVER 6 HOURS WAS ASSOCIATED WITH HIGHER HOSPITAL MORTALITY IN PATIENTS WITH SEPSIS
140RISK FACTORS FOR MORTALITY ON PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN VIETNAM
141A CALCULOUS CHOLECYSTITIS: A FATAL COMPLICATION IN POST-LUNG TRANSPLANTATION PATIENT – A CASE REPORT
141PREDICTION OF PRONE POSITION VENTILATION RESPONSE FOR ACUTE RESPIRATORY DISTRESS SYNDROME WITH HIGH-RESOLUTION COMPUTED TOMOGRAPHY
141CROSS SECTIONAL PREVALENCE STUDY ON PAEDIATRIC PATIENTS DIAGNOSED WITH SEVERE DENGUE AT A TERTIARY HOSPITAL IN CEBU CITY GIVEN NON INVASIVE VENTILATION VS MECHANICAL INTUBATION
142MIGRATING ORTHOPAEDIC PIN PRESENTING AS HAEMOPTYSIS IN A 10 YEAR OLD MALE: A CASE REPORT
142FACTORS ASSOCIATED WITH POOR OUTCOME IN SEPSIS PATIENTS WITH LIVER CIRRHOSIS
143WEANING PRACTICES AMONG PATIENTS WITH PNEUMONIA ON VENTILATORY SUPPORT AT CHINESE GENERAL HOSPITAL AND MEDICAL CENTER
143NEUTROPHIL-TO-LYMPHOCYTE RATIO AND BLOOD PLATELET COUNT CAN BE PROGNOSTIC MARKERS IN ACUTE RESPIRATORY DISTRESS SYNDROME PATIENTS OF DIFFERENT IMMUNE STATES
143HYPERCAPNIA DURING WEANING FROM PROLONGED VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION IN ACUTE RESPIRATORY DISTRESS SYNDROME
144IMPACT OF PATIENT- AND FAMILY-CENTRED CARE MEETINGS ON INTENSIVE CARE RESOURCE UTILISATION IN TERMINALLY ILL PATIENTS: A SINGLE-CENTRE RETROSPECTIVE OBSERVATIONAL STUDY IN TAIWAN
144FACTORS ASSOCIATED WITH HIGH FLOW OXYGEN THERAPY FAILURE IN ACUTE HYPOXEMIC RESPIRATORY FAILURE PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
144FIRST CASE OF ACUTE RESPIRATORY DISTRESS SYNDROME AND ALIMENTARY TRACT HAEMORRHAGE FOLLOWING MASS INGESTION OF METHYLISOTHIAZOLINONE
145PHYSICAL FUNCTION AFTER PULMONARY REHABILITATION AS A PREDICTOR OF WEANING SUCCESS AND SHORT-TERM AND MID-TERM SURVIVAL IN PATIENTS REQUIRING PROLONGED MECHANICAL VENTILATION
145AN OPTIMIZING MEDICAL MANAGEMENT FOR ACUTE HYPERCAPNIC RESPIRATORY FAILURE DUE TO ACUTE EXACERBATION COPD
146CLINICAL PARAMETERS AND SERUM BIOMARKER FOR INFLUENCING ICU MORTALITY IN SEVERE SEPSIS PATIENTS
146SINGLE-CENTRE RETROSPECTIVE STUDY OF ADMISSIONS TO THE MEDICAL INTENSIVE CARE UNIT (MICU) AND THE UTILITY OF LACTATE PROCALCITONIN PRODUCT IN PREDICTING MORTALITY
147EXTRACORPOREAL MEMBRANE OXYGENATION APPLICATION IN PREGNANT PATIENT WITH UROSEPSIS ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME – A CASE REPORT
147THE EFFECTIVENESS OF BRONCHOSCOPY IN RESPIRATORY FAILURE PATIENTS
147SEVERE INFLUENZA IN THE INTENSIVE CARE UNITS IN 2018: EXPERIENCE OF A REGIONAL HOSPITAL
148INCIDENCE AND CLINICAL OUTCOMES OF DELIRIUM IN CRITICALLY ILL MEDICAL PATIENTS IN A TERTIARY UNIVERSITY TEACHING HOSPITAL
148DIFFERENT PAO2/FIO2 MEASURING TIME CATEGORIZES DIFFERENT SEVERITY OF LUNG INJURY IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME: A PROSPECTIVE STUDY
148COMPARISON OF REINTUBATION RATE AND MORTALITY BY HIGH FLOW NASAL CANNULA AND CONVENTIONAL OXYGEN THERAPY IN POST-EXTUBATION PATIENT :A SYSTEMATIC REVIEW AND META-ANALYSIS
149OUTCOMES OF UNPLANNED EXTUBATION IN ORDINARY WARD ARE SIMILAR TO THOSE IN INTENSIVE CARE UNIT: A RETROSPECTIVE CASE-CONTROL STUDY
ENVIRONMENTAL & OCCUPATIONAL HEALTH AND EPIDEMIOLOGY 1
149PARTICULATE MATTER INCREASES EOSINOPHILIC AIRWAY INFLAMMATION
150THE EFFECTS OF AMBIENT FINE PARTICULATES ON 1-YEAR CHANGES OF LUNG FUNCTION AMONG THE ELDERS IN TAIWAN
150AUTOPHAGY INVOLVED OXIDATIVE STRESS INDUCED BY ATMOSPHERIC FINE PARTICLES (PM2.5) IN MOUSE ALVEOLAR MACROPHAGES (MH-S)
150DEVELOPMENT OF COMMUNITY PHARMACY TO THE CENTER OF SMOKING CESSATION, INITIATIVE IN THAILAND
151ROLE OF NRF2 IN LUNG INJURY INDUCED BY DIESEL EXHAUST
151PREVALENCE,RESPIRATORY SYMPTOMS AND RISK OF COPD AMONGPNEUMOCONIOSIS PATIENTS IN CHINA: A CROSS-SECTIONAL STUDY
151PREVALENCE OF RESPIRATORY DISORDERS IN PILGRIMS TRAVELLING TO INDIA FROM CENTRAL SRI LANKA
152SCREENING FOR RESPIRATORY DISEASES AMONG BISCUIT FACTORY EMPLOYEES IN CENTRAL SRI LANKA
152SOCIOLOGIC ASSESSMENT OF THE DEGREE OF APPLICATION OF LUNG FUNCTION EXAMINATION IN PULMONOLOGICAL PRACTICE
152RESOURCES OF PULMONOLOGY ON THE TERRITORY OF THE FAR EAST OF RUSSIA: SOCIAL-ECONOMIC STRATIFICATION AND REGIONAL GRADIENTS
153AGE AND GENDER DISTRIBUTIONS AMONG CHRONIC COUGH PATIENTS IN CHINA: COUGH IS NOT A SIMPLE REFLECTION OF COUGH REFLEX SENSITIVITY
153A CASE STUDY OF SILICOSIS ASSOCIATED PROGRESSIVE MASSIVE FIBROSIS AND SCLERODERMA
INTERSTITIAL LUNG DISEASE 1
154BEYOND DEPRESSION AND ANXIETY. A COMPREHENSIVE ASSESSMENT OF THE PSYCHOLOGICAL HEALTH OF PEOPLE DIAGNOSED WITH IPF AND THEIR CAREGIVERS
154DIFFERENCE OF THE CLINICAL CHARACTERISTICS AND OUTCOME BETWEEN CONNECTIVE TISSUE DISEASES ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
154CLINICAL FEATURES OF PATIENTS WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS WHO HAVE CIRCULATING ANTI-MDA5 AUTOANTIBODIES WITH INTERSTITIAL PNEUMONIA
155FIVE CASES OF ANTI-MDA-5(ANTI-CADM140) POSITIVE CLINICALLY AMYOPATHIC DERMATOMYOSITIS(CADM) WITH INTERSTITIAL PNEUMONIA
155CLINICAL FEATURES AND PROGNOSTIC FACTORS FOR SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE
155DIGESTIVE ADVERSE EVENTS FOLLOWING NINTEDANIB ADMINISTRATION IN IDIOPATHIC PULMONARY FIBROSIS
156SERUM SOLUBLE IL-2 RECEPTOR IS A POSSIBLE PROGNOSTIC BIOMARKER IN IDIOPATHIC INTERSTITIAL PNEUMONIA
156PULMONARY LANGERHANS CELL HISTIOCYTOSIS ASSOCIATED WITH SEVERE PULMONARY ARTERIAL HYPERTENSION: REPORT OF A CASE
157MORPHOLOGICAL ANALYSIS OF ALVEOLAR MACROPHAGE IN PATIENTS WITH PULMONARY ALVEOLAR PROTEINOSIS: LET'S REFLECT THE CELL ON A BRONCHOALVEOLAR FLUID SPECIMEN-PART 1
157THE PREVALENCE OF "CLINICAL PPFE "IN DAILY MEDICAL PRACTICE: TWO YEARS' EXPERIENCE AT A MEDICAL CENTER IN JAPAN
157GOOD LUNG FUNCTION BUT PROGRESSIVE RAYNAUD'S PHENOMENON IN A PATIENT OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER BILATERAL LUNG TRANSPLANTATION
158EXPLORING THE RELATIONSHIP BETWEEN THE PATHOPHYSIOLOGY OF PULMONARY HYPERTENSION (PH) AND THE STATUS OF INTERSTITIAL PNEUMONIA (IP) IN IP-ASSOCIATED PH
158EXTERNAL THERAPY OF TRADITIONAL CHINESE MEDICINE FOR IDIOPATHIC PULMONARY FIBROSIS: A LITERATURE ANALYSIS
158ANALYSIS OF CLINICAL FACTORS DECIDING NECESSITY TO TREAT INTERSTITIAL PNEUMONIAS POSITIVE FOR ANTI-AMINOACYL-TRNA SYNTHETASE ANTIBODIES
158CRYPTOCOCCUS NEOFORMS INDUCED HYPERSENSITIVITY PNEUMONITIS: A CASE REPORT
159BLEOMYCIN-INDUCED IPF MODEL IS ASSOCIATED WITH CELL CYCLE ARREST IN LUNG EPITHELIAL CELL
159THE ROLE OF FOLLOW-UP EVALUATION IN THE DIAGNOSTIC ALGORITHM OF IDIOPATHIC INTERSTITIAL PNEUMONIA: A RETROSPECTIVE STUDY
160INVESTIGATION OF INTRODUCTION OF NINTEDANIB FOR IDIOPATHIC PULMONARY FIBROSIS IN OUR HOSPITAL
160LUNG TRANSPLANT REFERRALS FOR IDIOPATHIC PULMONARY FIBROSIS PATIENTS IN HONG KONG
160RESPIRATORY BRONCHIOLITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (RB-ILD) PRESENTS WITH PROGRESSIVE DYSPNEA - A CASE REPORT
160THIS ABSTRACT HAS BEEN WITHDRAWN
160SAFETY OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A REAL-LIFE STUDY AT OUR HOSPITAL
161REVIEW ANALYSIS FOR CLINICAL CHARACTERISTICS OF INTERSTITIAL LUNG DISEASE ACCOMPANIED WITH LUNG CANCER (ILD-LC)
161SPORADIC LYMPHANGIOLEIOMYOMATOSIS PRESENTING AS SPONTANEOUS PNEUMOTHORAX: A CASE REPORT
161HYALURONAN IN BRONCHOALVEOLAR LAVEGE FLUID FROM PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS
162OBSERVATION ON THERAPEUTIC EFFICACY OF GN-CSF INHALAFION IN PATIENTS WITH RECURRENT PULMONARY ALVEOLAR PROTEINOSIS
162DISEASE ACTIVITY IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS ANALYZED BY A MULTIPLEX IMMUNOASSAY SYSTEM
162CASE OF TUBEROUS SCLEROSIS COMPLEX WITH PULMONARY LYMPHANGIOLEIOMYOMATOSIS AND ANGIOMYOLIPOMAS OF THE LIVER AND KIDNEY
LUNG CANCER 1
162A CASE OF RESECTED LUNG METASTASIS FROM UTERINE LEIOMYOSARCOMA
163FUCOSYLTRANSFERASE 4 PROMOTES CANCER METASTASIS VIA ENHANCING GLYCOSYLATION OF EGFR/TGFBR SIGNALING NETWORK IN NON-SMALL CELL LUNG CANCER
163EXPERIENCE ON HYPERPROGRESSION DISEASE (HPD) BY IMMUNOTHERAPY FOR LUNG CANCER
163STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR EARLY STAGE OF NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE, SINGLE-INSTITUTIONAL EXPERIENCE
164PRIMARY THYMIC CARCINOMA, CLEAR CELL TYPE: A CASE REPORT
164PROGNOSTIC EFFECT OF SERUM OXIDATIVE STRESS LEVEL ACCORDING TO SMOKING STATUS IN PATIENTS WITH CURATIVELY RESECTED STAGE I NON-SMALL CELL LUNG CANCER
165THE ROLE OF THE CIRCULATING TUMOR CELLS IN THE SOLITARY PULMONARY NODULES
165A CASE OF OSTEOSARCOMA LUNG METASTASIS WITH LONG-TERM SURVIVAL BY MULTIDISCIPLINARY TREATMENT CENTERED ON MULTIPLE SURGICAL EXCISION
165ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER –EXPERIENCE FROM TAIWAN
165IMMUNOTHERAPY IN NSCLC PATIENTS POSITIVE FOR ANA COULD BE HIGH-RISK AND HIGH-RETURN
166LONG-TERM NICOTINE EXPOSURE IN LUNG CANCER
166RESPIRATORY MUSCLE STRENGTH, EXERCISE CAPACITY, AND DYSPNEA DURING PULMONARY REHABILITATION AFTER LOBECTOMY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
166THE FREQUENCY OF EGFR MUTATION AND ALK REARRANGEMENT IN PATIENTS WITH LUNG ADENOCARCINOMA: THE EXPERIENCE OF A LOCAL HOSPITAL IN TAIWAN
167RAPID DIAGNOSIS OF THORACIC LYMPH NODE METASTASIS IN PATIENTS WITH LUNG CANCER DURING SURGERY BY DIELECTRIC PROPERTY TEST
167EFFICACY AND SAFETY OF ANTI-PD-L1 ANTIBODY IN NSCLC PATIENTS WHO PREVIOUSLY TREATED WITH ANTI PD-1 ANTIBODIES: PRELIMINARY STUDY
167A COMPREHENSIVE ANALYSIS OF PD-L1 EXPRESSION IN LUNG CANCER PATIENTS: WITH EMPHASIS ON THE IMPACT OF ARCHIVAL TISSUE
168THE INCIDENCE OF EGFR MUTATIONS IN PATIENTS WITH ADENOCARCINOMA
168EFFECTIVENESS OF TREATMENTS IN ADVANCED NON-SMALL CELL LUNG CANCER WITH EXON 20 INSERTION EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
168MICRORNA EXPRESSION PROFILING FOR IDENTIFYING MALIGNANT PLEURAL EFFUSION IN PATIENTS WITH LUNG ADENOCARCINOMA
168TEXTURE ANALYSIS PREDICTING EGFR MUTATION AND RECURRENCE IN LUNG ADENOCARCINOMA
169DIFFERENCES OF CLINICAL FEATURES BASED ON PD-L1 EXPRESSION IN JAPANESE LUNG CANCER PATIENTS
169NON-SMALL CELL CARCINOMA OF THE LUNG INITIALLY PRESENTING AS LUNG ABSCESS
169OSIMERTINIB COMBINED WITH CETUXIMAB FOR NON-SMALL CELL LUNG CANCER (NSCLC) WITH T790M AND C797S MUTATIONS
170NO TIME TO LOSE- UNDERSTANDING HOW VARIATION IN PRACTICE AFFECTS LENGTH OF STAY FOR PATIENTS WITH MALIGNANT PLEURAL EFFUSION
170DNA DEMETHYLATING AGENTS SENSITIZE IMMUNE-BASED CYTOTOXICITY BY UPREGULATING IMMUNE SYNAPSE MOLECULES ON LUNG CANCER CELLS
171A CASE OF PSEUDOMESOTHELIOMATOUS LUNG CANCER IN PATIENT WITHOUT EXPOSURE TO ASBESTOS
171METFORMIN PROLONGS SURVIVAL IN LUNG CANCER EGFR-TKIS PATIENTS
171NORTHERN MALAYSIA PULMONOLOGY CENTRE EXPERIENCE AND ANALYSIS OF PROGRESSION FREE SURVIVAL RATE WITH TYROSINE KINASE INHIBITORS IN MANAGING ADVANCED ADENOCARCINOMA OF LUNG
172AN IMMUNE PROFILE OF TUMOR PD-L1 EXPRESSION PLUS CD4 OR CD8 T CELL INFILTRATIONS CORRELATED WITH TREATMENT EFFICACY OF PD-1 BLOCKADE ANTIBODIES IN NSCLC PATIENTS
172SMALL CELL LUNG CANCER TRANSFORMATION AND T790M MUTATION COEXISTING AFTER SUBSEQUENT FIRST AND THIRD GENERATION EGFR-TKI THERAPY: A RARE CASE REPORT AND LITERATURE REVIEW
173PULMONARY SCLEROSING PNEUMOCYTOMA IN AN ASYMPTOMATIC YOUNG ASIAN MAN: A CLINICOPATHOLOGIC CASE REPORT
173LUNG CANCER WITH SMALL BOWEL METASTASIS AND PERFORATION WITH CHEMOTHERAPY-NAÏVE STATUS, A RARE CASE REPORT AND LITERATURE VIEW
174CHYLOTHORAX IN MEDIASTINAL TUMOR
174ADVANCED NON-SMALL CELL LUNG CANCER WITH TONSIL METASTASIS, A CASE REPORT
174ADENYLATE CYCLASE-ASSOCIATED PROTEIN 1-TARGETED NANOPARTICLES AS A NOVEL STRATEGY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER
175A 3-YEAR STUDY ON THE INCIDENCE AND PREDICTORS OF EARLY COMPLICATIONS RESULTING FROM CT-GUIDED TRANSTHORACIC BIOPSY AT THE LUNG CENTER OF THE PHILIPPINES
175IMPACT OF ELDERLY ON ONE YEARS SURVIVAL RATES OF PATIENTS WITH NON SMALL CELL LUNG CANCER
175A CASE OF MALIGNANT PLEURAL MESOTHELIOMA THAT COMPLICATED WITH PERITONEAL DISSEMINATION DURING THE 10-YEAR SURVIVAL
176DISCOVERY THE NOVEL COMPOUND FOR OVERCOMING EGFR-TKI RESISTANCE IN LUNG ADENOCARCINOMA
176COMPARABILITY OF AUTOMATED IMAGE CYTOMETRY RESULTS OF BRONCHIAL WASHINGS WITH MANUAL CYTOLOGY AND HISTOPATHOLOGY IN DIAGNOSIS OF LUNG CANCER AT LUNG CENTER OF THE PHILIPPINES
177MULTIPLE PRIMARY LUNG CANCER OR RELAPSE? A REPORT OF TWO CASES
177THE RISK OF MECHANICAL VENTILATION IN PATIENTS WITH LUNG CANCER AT END-OF LIFE IN TAIWAN
177NIVOLUMAB-INDUCED SEVERE ACUTE KIDNEY INJURY WITH A LONG LATENT PHASE IN A PATIENT WITH NON-SMALL CELL LUNG CANCER: A CASE REPORT
178RISK FACTORS OF LUNG CANCER IN MALE NEVER-SMOKERS IN PERSAHABTAN NATIONAL HOSPITAL
178MOLECULAR BIOLOGICAL ANALYSIS IN A PATIENT WITH MULTIPLE LUNG ADENOCARCINOMA
PAEDIATRIC LUNG DISEASE 1
178THERAPEUTIC EFFECT OF LEUKOTRIENE RECEPTOR ANTAGONIST MONTELUKAST IN TREATMENT OF RESPIRATORY TRACT MYCOPLASMAL INFECTIONS IN CHILDREN
179THIS ABSTRACT HAS BEEN WITHDRAWN
179AN UNEXPECTED FINDING OF PERSISTENT RIGHT LUNG COLLAPSE; CHILDHOOD ENDOBRONCHIAL TUMOUR: A CASE REPORT
179MASSIVE HAEMOPTYSIS IN CHILDREN DUE TO INTRALOBAR PULMONARY SEQUESTRATION (CASE REPORT)
179PULMONARY INTRALOBAR SEQUESTRATION WITH CONGENITAL PULMONARY AIRWAY MALFORMATION TYPE II (CPAM TYPE II)
PULMONARY CIRCULATION 1
180PULMONARY ARTERIOVENOUS MALFORMATION PRESENTING AS RECURRENT ISCHEMIC STROKE: A CASE REPORT
180RISK OF SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS FOLLOWING APPENDECTOMY: A NATIONWIDE COHORT STUDY
180HAEMOPTYSIS DUE TO A RARE CAUSE IN THREE PATIENTS FROM CENTRAL SRI LANKA
181AIR-CRESCENT IS NOT ALWAYS INFECTIOUS EVENT
181PATHWAYS HSA_CIRC_0026480–MIR-27A-3P–ATXN1 AND HSA_CIRC_0046159–MIR-1226-3P–ATP2A2 ARE INVOLVED IN THE DEVELOPMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 1
182THE PHYSICIAN'S PERSPECTIVES ON THE DEFINITION, CLINICAL PRACTICES AND CLINICALLY IMPORTANT OUTCOMES IN THE MANAGEMENT OF ACUTE BRONCHIOLITIS IN THE TERTIARY HOSPITALS OF CEBU CITY, PHILIPPINES
183DIAGNOSTIC PREDICTIVE FACTOR OF ADENOVIRAL PNEUMONIA IN PATIENTS ADMITTED FOR COMMUNITY-ACQUIRED PNEUMONIA IN Republic of Korea MILITARY TRAINEES
183CT-GUIDED DRAINAGE FOR LUNG ABSCESS
183PROGRESSIVE DISSEMINATED HISTOPLASMOSIS DERIVED FROM ACUTE PULMONARY HISTOPLASMOSIS IN A 61-YEAR-OLD MALE IN NORTH-WESTERN CHINA: A CASE REPORT AND REVIEW OF LITERATURE
184CLINICAL SIGNIFICANCE OF SERUM PRESEPSIN LEVEL IN HOSPITALIZED PNEUMONIA
184INFLAMMATORY TRACHEOBRONCHITIS: A RARE PRESENTATION OF PSEUDOMONAS AERUGINOSA INFECTION
184TRANSBRONCHIAL INSTILLATION OF LIPOSOMAL AMPHOTERICIN B: TOPICAL THERAPY FOR CHRONIC PROGRESSIVE PULMONARY ASPERGILLOSIS
185TANREQING INJECTION FOR BRONCHIECTASIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
185RETROSPECTIVE ANALYSIS OF SURGERY FOR THE MANAGEMENT OF PARAPNEUMONIC PLEURAL EFFUSION AND ACUTE EMPYEMA
186PULMONARY INFECTIONS IN POST-LUNG TRANSPLANTATION PATIENTS: CASE SERIES OF A TERTIARY MEDICAL CENTER IN TAIWAN
186MULTICENTER SURVEY OF POST-INFLUENZA RESPIRATORY COMPLICATIONS IN THE SEASON BETWEEN 2017 AND 2018 IN TOKYO CENTRAL AREA
186FREQUENT EMPIRIC BROAD-SPECTRUM ANTIMICROBIAL USE AMONG HOSPITALIZED PATIENTS WITH LOWER RESPIRATORY TRACT INFECTION IN SOUTHERN SRI LANKA
187ROLE OF BRONCHOSCOPY FOR PATHOGEN DIFFERENTIATION IN PATIENTS WITH EMPYEMA
187RISK FACTORS OF DISCONTINUATION OF MULTIPLE DRUGS TREATMENT OF MAC LUNG DISEASE
187UTILIZATION OF PROCALCITONIN AS A DIAGNOSTIC BIOMARKER OF PEDIATRIC VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH CONGENITAL HEART DISEASE FOLLOWING CARDIAC SURGERY
188SINGLE-TROCAR VIDEO-ASSISTED FLEXIBLE THORACOSCOPIC DEBRIDEMENT UNDER LOCAL ANAESTHESIA FOR MULTILOCULATED PARAPNEUMONIC EMPYEMA
188URINARY ANTIGEN TESTING IN COMMUNITY-ACQUIRED PNEUMONIA: CLINICAL UTILITY, COST EFFECTIVENESS AND THE IMPACT ON ANTIBIOTIC TREATMENT
189EFFICACY OF CORTICOSTEROID ADMINISTRATION IN SEVERE COMMUNITY-ONSET PNEUMONIA PATIENTS: USING THE JAPANESE DIAGNOSTIC PROCEDURE COMBINATION DATABASE
189RISK FACTORS AND IMPLICATIONS FOR READMISSION OF PATIENTS FOLLOWING HOSPITALIZATION FOR COMMUNITY-ACQUIRED PNEUMONIA IN Republic of Korea
189RARE PRESENTATION OF HYDATID CYST
190A CASE OF PRIMARY MEDIASTINAL ACTINOMYCOSIS PRESENTED WITH RECURRENT LYMPHOCYTE-PREDOMINANT PLEURAL EFFUSION
190EFFECTS OF INTRAVENA N-ACETYLCYSTEIN ON NEUTROPHIL, PROCALCITONIN, C REACTIVE PROTEIN AND LENGTH OF CLININICAL IMPROVEMENT IN COMMUNITY ACQUIRED PNEUMONIA
191CHARACTERISTICS OF PATIENTS WITH HIGH MYCOBACTERIUM-AVIUM COMPLEX ANTIBODY
191IFN-γ RESPONSE TO PPD STIMULATION IN NON-TUBERCULOUS MYCOBACTERIAL PATIENTS MAY DISTINGUISH ACTIVE STAGE FROM CHRONIC ONE
191RETROSPECTIVE ANALYZE THE CLINICAL APPLICATION OF CRYPTOCOCCAL ANTIGEN (COLLOIDAL GOLD METHOD) TO DETECT PULMONARY CRYPTOCOCCOSIS
192PNEUMONIA IN EARLY POST-KIDNEY TRANSPLANT PERIOD; A RETROSPECTIVE COHORT STUDY
192PULMONARY NOCARDIA INFECTION PRESENTING AS MULTIPLE LUNG MASSES
192KARTAGENER'S SYNDROME: A RARE CASE REPORT IN MALE
193CLINICAL EFFICACY AND COST-EFFECTIVENESS ANALYSIS OF CEFEPIME OR PIPERACILLIN/TAZOBACTAM BOTH WITH CIPROFLOXACIN IN MICU PATIENTS WITH SEVERE PNEUMONIA
193IMPORTANCE AND EFFICACY OF CONCURRENT INTRAVENOUS COLISTIN WITH NEBULIZED COLISTIN FOR VENTILATOR-ASSOCIATED PNEUMONIA COMPARED WITH ONLY INTRAVENOUS COLISTIN
193THE EFFECT OF PROCALCITONIN-GUIDED THERAPY ON PRESCRIPTION AND DURATION OF ANTIBIOTICS AMONG PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA: A META-ANALYSIS
RESPIRATORY NEUROBIOLOGY AND SLEEP 1
194A CASE REPORT ON BILATERAL DIAPHRAGMATIC DYSFUNCTION DUE TO BILATERAL PHRENIC NERVE NEUROPATHY IN A 65-YEAR-OLD MALE WITH DYSPNEA ON SUPINE POSITION
194ABERRANT DNA METHYLATION LEVELS OF THE FORMYL PEPTIDE RECEPTOR 1/2/3 GENE PROMOTER REGIONS ARE ASSOCIATED WITH OBSTRUCTIVE SLEEP APNOEA
195USING NOSAS SCORE TO PREDICT SEVERE OBSTRUCTIVE SLEEP APNEA IN A CLINIC-BASED POPULATION
195TOO LITTLE O2, TOO MUCH HGB
196CPAP ADHERENCE IN ADULTS WITH NEWLY DIAGNOSED OSAHS AND RELATED INFLUENTIAL FACTORS: A STUDY IN CHANGSHA, CHINA
196HOW DOES THE OBSTRUCTIVE SLEEP APNEA INFLUENCE THE SLEEP EFFICIENCY, SLEEPINESS, AND NEUROCOGNITIVE FUNCTION IN PATIENTS WITH REM SLEEP BEHAVIOUR DISORDER
197RETROSPECTIVE OBSERVATIONAL STUDY OF OBSTRUCTIVE SLEEP APNOEA IN WOMEN IN NORTHERN TERRITORY AUSTRALIA
197THE USE OF CONTINUOUS PULSE OXIMETRY IN THE DIAGNOSIS OF DEVENTILATION SYNDROME IN A CASE OF KYPHOSCOLIOSIS WITH CHRONIC VENTILATORY FAILURE
197DYSPNEA IMPROVEMENT IN PATIENTS WITH LUNG DISEASES IN A SINGLE SESSION OF MINDFUL BREATHING: A RANDOMIZED CONTROLLED STUDY
198TREATMENT EMERGENT SLEEP APNEA: A CASE REPORT
RESPIRATORY STRUCTURE AND FUNCTION 1
198NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RESPIRATORY FUNCTIONS
198THE WEIGHT LOSS THERAPY IMPROVED RESPIRATORY FUNCTION AND RESPIRATORY SYSTEM IMPEDANCE IN OBESE SUBJECTS
199PRIMARY MEDIASTINAL SEMINOMA PRESENTING AS SUPERIOR VENA CAVA SYNDROME: A CASE REPORT
199THE CORRELATION BETWEEN RESPIRATORY FUNCTION AND GAIT ASYMMETRY IN STROKE PATIENTS
199LEFT BRONCHIAL ISOMERISM PRESENTED AS A SEVERE OBSTRUCTIVE VENTILATORY DISTURBANCE IN A HEALTHY ADULT
200RELATIONSHIP BETWEEN LOW-FREQUENCY INTERVENTION FOR INSPIRATORY MUSCLE TRAINING AND COUGH PEAK FLOW IN HEALTHY YOUNG ADULTS
200DECLINE IN LUNG FUNCTION IS ASSOCIATED WITH ELEVATED LIPOPROTEIN A LEVELS IN KOREAN HEALTH SCREENING SUBJECTS WITHOUT CLINICALLY APPARENT DISEASE: A CROSS-SECTIONAL STUDY
200TRAUMATIC CHYLOTHORAX IN YOUNG CHILDREN: CASE SERIES AND MANAGEMENT
201COMPARISON OF THE EFFICIENCY OF ORAL AIRWAY AND NASAL AIRWAY INSERTED IN THE ORAL AIRWAY DURING MASK VENTILATION
TUBERCULOSIS 1
201IMPACT OF ADDITIONAL ANTIBIOTICS ON IN-HOSPITAL MORTALITY IN PULMONARY TUBERCULOSIS COMPLICATED BY BACTERIAL PNEUMONIA: A PROPENSITY SCORE ANALYSIS
201A NOVEL COMBINATIVE ADJUNCT THERAPY TARGETING HOST NUCLEAR RECEPTORS MINIMIZES TUBERCULOSIS TREATMENT REGIMEN
202PROFOUND CD4 LYMPHOPENIA IN A NON HIV PATIENT WITHMILIARY TUBERCULOSIS, PRESENTING WITH AN AIDS DEFINING INFECTION
202THE PROGNOSTIC FACTORS AMONG ELDERLY PATIENTS WITH LUNG TUBERCULOSIS: A COMPETING RISK ANALYSIS
203CORRELATION BETWEEN RADIOLOGIC ACTIVITIES ON CHEST CT WITH MICROBIOLOGIC RESULTS VIA BRONCHOSCOPY IN PULMONARY TUBERCULOSIS
203THE CORRELATION BETWEEN INTERFERON-γ AND INTERLEUKIN-17 LEVELS TO THE CHEST RADIOGRAPHIC INTERPRETATION IN RIFAMPICIN-RESISTANCE AND RIFAMPICIN-SENSITIVE PULMONARY TUBERCULOSIS
204CLINICAL OUTCOMES OF TAILORED VS STANDARD ANTI-TUBERCULOSIS THERAPY IN PATIENTS WITH TUBERCULOUS LYMPHADENITIS
204NEUTROPHIL-LYMPHOCYTE COUNT RATIO (NLR) WAS ASSOCIATED WITH DISEASE ACTIVITY IN TUBERCULOSIS AND DIABETIC MELLITUS PATIENTS
204THE COMPLIANCE AND SIDE EFFECTS OF 3HR THERAPY IN LATENT TUBERCULOSIS INFECTION
205CORTICOSTEROIDS FOR MANAGING TUBERCULOUS SEROSITIS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
205IMPACT OF non-tuberculous MYCOBACTERIA COLONIZATION OR INFECTION ON MULTIDRUG RESISTANCE TUBERCULOSIS TREATMENT
205EXTRA PULMONARY TUBERCULOSIS IN HIV PATIENTS:PROFILE & OUTCOME OF PATIENTS AT WESTERN VISAYASMEDICAL CENTER PPMD DOTS UNIT PHILIPPINESJANUARY 2015 TO JUNE 2018
206A CASE OF TUBERCULOUS SPONDYLITIS FOLLOWING INTRAVESICAL BCG THERAPY
206PERFORMANCE OF GENEXPERT MTB/RIF ASSAY IN PULMONARY AND EXTRAPULMONARY SAMPLES IN REAL WORLD SETTING
206LOW INCIDENCE OF DRUG INDUCED HEPATITIS IN 4 MONTHS RIFAMPICIN REGIMEN FOR THE PREVENTIVE CHEMOTHERAPY OF LATENT TUBERCULOSIS INFECTION
207CLINICAL DIFFERENCES BETWEEN POSITIVE AFB AND NEGATIVE AFB IN LUNG TUBERCULOSIS PATIENTS IN INDONESIA
207KNOWLEDGE, ATTITUDES AND PRACTICES REGARDING PULMONARY TUBERCULOSIS AMONG HIGH RISK HEALTH CARE WORKERS IN UST HOSPITAL
207CHARACTERISTICS OF TUBERCULOSIS PATIENTS WITH AFB SPUTUM SMEAR EXAMINATION POSITIVE AT PULMONARY HEALTH CENTER (BALAI KESEHATAN PARU MASYARAKAT) IN BANYUMAS, CENTRAL JAVA, INDONESIA
208A CROSS-SECTIONAL STUDY TO PROFILE NON-CYSTIC FIBROSIS BRONCHIECTASIS IN MALAYSIA
208FACTORS PREDICTING THE NEED OF INTENSIVE CARE IN PATIENTS WHO WERE ADMITTED FOR PULMONARY TUBERCULOSIS
208ELIGIBILITY OF SHORTER REGIMEN (STR) AMONG MULTIDRUG RESISTANT TUBERCULOSIS PATIENTS IN PERSAHABATAN HOSPITAL, INDONESIA
209ACQUIRED BRONCHOESOPHAGEAL FISTULA IN ADULT FILIPINO
209SOLITARY PULMONARY NODULES DUE TO NON-TUBERCULOUS MYCOBACTERIAL INFECTION DIAGNOSED WITH VIDEO-ASSISTED THORACOSCOPIC SURGERY
210LATENT TUBERCULOSIS INFECTION AND TREATMENT STATUS OF NORTH KOREAN REFUGEES
210PRIMARY MDR TB CASES IN WEST SUMATERA
ASTHMA 2
211DEVELOPMENT OF A COST-EFFECTIVENESS MODEL TO ASSESS ASTHMA INHALER ADHERENCE AND TECHNIQUE INTERVENTIONS
211IMPACT OF OMALIZUMAB IN TREATMENT OF SEVERE ALLERGIC ASTHMA: PERSPECTIVE FROM SINGLE CENTER EXPERIENCE IN MALAYSIA
211PRODUCTION OF REACTIVE NITROGEN SPECIES IN ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP
212TRIMETHYLAMINE-N-OXIDE REVERSES AUTOPHAGIC DYSFUNCTION IN THE LUNG TISSUES OF OVA-OVA BRONCHIAL ASTHMA MICE
212THE CONDITION OF LUNG FUNCTION IN PATIENTS WITH ASTHMA DEPENDING ON THE BODY MASS
212FACTORS ASSOCIATED WITH EFFICACY OF TIOTROPIUM IN PATIENTS WITH ASTHMA
213BRONCHIAL THERMOPLASTY SUCCESS IN ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP: A CASE REPORT
213THE EFFICACY OF A STRUCTURED ASTHMA DISEASE MANAGEMENT PROGRAM IMPACTS ON OVERALL CONTROL OF ASTHMA & QUALITY OF LIFE OF ASTHMA PATIENTS
213PHYSICIANS' PERCEPTION ON PATTERNS OF DIAGNOSING AND MANAGING ASTHMA: A SURVEY IN MYANMAR
213THE POTENTIAL ROLE OF SERUM TGF-β AS A BIOMARKER FOR ASTHMA
214NOVEL ASSOCIATION BETWEEN ASTHMA AND OSTEOARTHRITIS
214A COMPLIANCE STUDY OF THE MANAGEMENT OF PATIENTS WITH ASTHMA AGAINST THE GLOBAL INITIATIVE FOR ASTHMA (GINA) GUIDELINES 2016
214NEUTROPHILIC INFLAMMATION OF THE UPPER AIRWAYS IS A CHARACTERISTIC FEATURE OF MACROLIDE RESPONDERS IN PATIENTS WITH ASTHMA
215THE ASTHMA EXACERBATION AFTER INHALED CORTICOSTEROID WITHDRAWAL: THE ANALYSES OF THE NATIONAL HEALTH INSURANCE DATABASE
215ASSESSMENT OF THE ACTUAL CONDITION OF ELDERLY ASTHMA
215THE SITUATION OF SERVICE IN PATIENT WITH ASTHMA EXACERBATION, EXPERIENCE IN SECONDARY CARE HOSPITAL, THAILAND
216BITTER TASTE RECEPTOR AND ITS ROLE OF RELIEVING BRONCHOSPASM FOR THE ASTHMATICS- AN EVIDENCE-BASED MEDICINE UPDATE, 2018
216THE CHANGE OF NASAL RESISTANCE AT THE ACUTE NASAL CHALLENGE WITH COLD AIR IN ASTHMATICS WITH COLD AIRWAY HYPERRESPONSIVENESS
216POLY-UNSATURATED FATTY ACIDS METABOLOMICS STUDY REVEALS CHILDHOOD SERUM HETES LEVELS CLOSELY RELATED TO GLUTATHIONE PEROXIDASES IN ALLERGIC ASTHMA
217RESOLVIN E3 ATTENUATES ASTHMATIC INFLAMMATION IN A MURINE MODEL OF HOUSE DUST MITE (HDM) -INDUCED AIRWAY INFLAMMATION
217EFFECT OF NEBULIZED INHALED TRIPTOLIDE IN MOUSE MODEL OF ASTHMA
217VALIDATION OF RISK FACTORS OF ASTHMA ATTACK QUESTIONNAIRE AMONG MALAYSIAN ADULT ASTHMATIC PATIENTS
218THE DIFFERENT RELATIONSHIP IN SINGLE NUCLEOTIDE POLYMORPHISMS OF CHITINASE 3-LIKE 1 (CHI3L1) GENE, CHI3L1 SERUM LEVEL, WITH BRONCHIAL ASTHMA AND ALLERGIC RHINITIS IN TAIWAN
218EFFECTIVENESS OF A LONG-TERM COMBINED THERAPY IN PATIENTS WITH PERSISTENT ASTHMA DEPENDS ON THE PATTERN OF INFLAMMATION AND AIRWAY RESPONSE TO COLD AIR
218THE CORRELATION OF AIRWAY RESPONSES TO OSMOTIC AND THERMAL STIMULI IN ASTHMATICS WITH EXERCISE-INDUCED BRONCHOCONSTRICTION
219THE FIRST EQUATION TO ESTIMATE THE SIX-MINUTE WALK DISTANCE IN HEALTHY MALAYSIAN ADULT AGED 20 TO 40 YEARS OLD
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 2
219COMPARISON OF RADIAL PROBE ENDOBRONCHIAL ULTRASOUND GUIDED AND BLIND TRANSBRONCHIAL LUNG BIOPSY IN DIFFUSE LUNG LESIONS
219ANALYSES OF LUNG SOUNDS BEFORE AND AFTER THE TREATMENTS FOR LARGE AIRWAY STENOSIS
220RIGHT MAIN BRONCHIAL PLEOMORPHIC ADENOMA: A RARE CASE REPORT AND LITERATURES REVIEW
220BRONCHOSCOPIC THERMAL VAPOUR ABLATION (BTVA) FOR SEVERE EMPHYSEMA: PRELIMINARY EXPERIENCE WITH A NOVEL INTERVAPOR® TECHNOLOGY IN A SINGAPORE TERTIARY HOSPITAL
221EFFICACY AND INFLUENCE FACTORS OF INTERVENTIONAL BRONCHOSCOPY FOR THE TREATMENT OF SCARRING AIRWAY STENOSIS
221FEASIBILITY OF RE-BIOPSY BY ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL ASPIRATION (EBUS-TBNA) IN PATIENTS WITH PREVIOUSLY TREATED LUNG CANCER
221TRACHEAL STENOSIS IN A YOUNG LADY FOLLOWING SHORT-TERM INTUBATION: MIMICKING ASTHMA
222COMPARISON OF DEXMEDETOMIDINE TO PROPOFOL FOR SEDATION OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION: A RANDOMIZED CONTROLLED TRIAL
222DIAGNOSIS OF PULMONARY FUNGUS BALL USING ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION: CASE REPORTS
222A CASE OF TRACHEOBRONCHOPATHIA OSTEOCHONDROPLASTICA OBSERVED ON ENDOBRONCHIAL ULTRASOUND
223DIAGNOSTIC YIELD AND SAFETY OF EBUS-TBNA AND PERIPHERAL EBUS GUIDED TBLB UNDER MODERATE SEDATION: A SINGLE-CENTER RETROSPECTIVE AUDIT
223ENDOBRONCHIAL TREATMENT OF BRONCHOPLEURAL FISTULAS BY USING OVAL FORAMEN OCCLUDER UNDER VIRTUAL BRONCHOSCOPIC NAVIGATION: A CASE
224PSEUDO-MEIGS' S SYDROME: CASE REPORT
224CLINICAL IMPACT OF A NEW 25 GAUGE ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE IN LYMPH NODE STAGING
225REMOVAL OF THE HIGH-RISK BRONCHIAL OSSEOUS FOREIGN BODY UNDER VIRTUAL BRONCHOSCOPE NAVIGATION AND FORMULATION
225THE USEFULNESS OF PLEURAL BIOPSY IN PLEURAL EFFUSION
225A NEW TECHNIQUE FOR SELF-EXPANDING METALLIC Y-SHAPED AIRWAY STENTS DEPLOYMENT, SAFE AND SIMPLE
226TRANSBRONCHIAL CRYOBIOPSY IN DIFFUSE PARENCHYMAL LUNG DISEASE: A CHINESE PERSPECTIVE
226NOVEL USE OF SPYSCOPE FOR PLACEMENT OF CATHETER IN RIGHT UPPER LOBE TO CONTROL BLEEDING DURING CRYOBIOPSY
226TWO YEARS EXPERIENCE OF INDWELLING PLEURAL CATHETER PLACEMENT FOR MALIGNANT AND RECURRENT PLEURAL EFFUSION IN SONGKLANAGARIND HOSPITAL
227DIAGNOSING MALIGNANCIES IN THE LUNG: THE QUALITY OF A BRONCHOSCOPY SERVICE AT A TERTIARY HOSPITAL
227BRONCHIAL LEIOMYOMA: A RARE BRONCHIAL TUMOR WITH UNCOMMON PRESENTATION OF RECURRENT HAEMOPTYSIS
227DIAGNOSTIC VALUE OF THORACOSCOPE FOR PLEURAL DISEASES IN INTERNAL MEDICINE
228CONCURRENT PROCEDURE OF PRIMARY TUMOUR BIOPSY USING NAVIGATIONAL EBUS BRONCHOSCOPY AND LYMPH NODE STAGE USING EBUS-TBNA IN LUNG CANCER PATIENTS WITH PERIPHERAL AND MEDIASTINAL LESIONS
228AETIOLOGY AND MANAGEMENT OF 131 PATIENTS WITH MAIN TRACHEAL STENOSIS
CELL AND MOLECULAR BIOLOGY 2
228VITEXIN MAY EXERTS ANTI-ALLERGIC INFLAMMATORY EFFECTS VIA ORAI1 CHANNEL INHIBITION
229INHIBITION OF NKCC1 MODULATES INFLAMMATION AND APOPTOSIS OF ALVEOLAR EPITHELIUM IN ISCHEMIA-REPERFUSION LUNG INJURY VIA NF-KB AND P38 MAPK PATHWAYS
229ASSOCIATION BETWEEN CIGARETTE SMOKING STATUS AND COMPOSITION OF GUT MICROBIOTA IN KOREAN MEN
229THE ROLE OF SODIUM-POTASSIUM-CHLORIDE COTRANSPORTER IN LPS-INDUCED ALVEOLAR MACROPHAGE ACTIVATION
230THE HYPOXIA-INDUCIBLE FACTOR 1α PROTEIN STABILIZER INHIBITS TRANSFORMING GROWTH FACTOR β-INDUCED EXTRACELLULAR MATRIX PROTEINS BEYOND CELL TYPES AND SPECIES
230HETERONEMIN INDUCES ROS-BASED MITOCHONDRIAL-MEDIATED APOPTOSIS IN LUNG CANCER CELLS
CLINICAL ALLERGY AND IMMUNOLOGY 2
230BRONCHOSCOPIC FEATURES OF RELAPSING POLYCHONDRITIS OF LARGE AIRWAYS AFTER TRACHEOSTOMY
231ONE-YEAR FOLLOW-UP STUDY OF PHARMACOKINETIC INTERACTIONS IN A TACROLIMUS-TREATED LUNG TRANSLPLANT PATIENT
231ASIA-PACIFIC SURVEY OF PHYSICIANS ON ASTHMA AND ALLERGIC RHINITIS (ASPAIR) – INDIA RESULTS
232METABOLOMIC PROFILING OF SERUM DURING ALLERGEN IMMUNOTHERAPY IN ASTHMATIC CHILDREN
CLINICAL RESPIRATORY MEDICINE 2
232THE ROLE OF HIGH ALTITUDE SIMULATION TEST (HAST) IN PATIENTS WITH PULMONARY DISEASE AND NORMAL OXYGEN SATURATION AT BASELINE
232HIGH ATTENUATION AREA ALONG THE BRONCHIAL WALL ON COMPUTED TOMOGRAPHY SUGGESTS THE IRON PILL ASPIRATION
233ACCURACY OF A SONOGRAPHIC SCORING INDEX IN THE CLASSIFICATION OF PLEURAL EFFUSION
233NIPPV (NON INVASIVE POSITIVE PRESSURE VENTILATION) CAN IMPROVE THE CLINICAL OUTCOMES OF THORACIC SURGERY PATIENTS
233IMPROVEMENT QUALITY OF LIFE IN MEDIASTINAL SOLITARY FIBROUS TUMOR PATIENT: CHEMOTHERAPY PALLIATIVE PERSPECTIVE
234THE ROLE OF IMMUNOHISTOCHEMISTRY IN A MALIGNANT PLEURAL EFFUSION FROM AN OCCULT PAPILLARY THYROID CARCINOMA: A CASE REPORT
234SUCCESSFUL MANAGEMENT OF LEPTOSPIROSIS ASSOCIATED DIFFUSE ALVEOLAR HEMORRHAGE USING AN EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
234RESPIRATORY EVENTS AND PROGNOSIS DURING PREGNANCY AND PERIPARTUM
235COMPARISON THE PULMONARY CAPACITY IN LUNG TRANSPLANTATION PATIENTS WITH AND WITHOUT PRE-TRANSPLANTATION PULMONARY REHABILITATION
235LATE-PRESENTING CONGENITAL DIAPHRAGMATIC HERNIA IN A 4-YEAR-OLD MALE: AN INCIDENTAL FINDING
236EVALUATION OF INHALED DRUG PROCEDURE AMONG PATIENTS WITH ASTHMA OR COPD
236THE CAUSE OF DYSPNEA WAS DIAGNOSED DURING EMERGENT ENDOTRACHEAL INTUBATION: A CASE REPORT OF TRACHEA, STENOSIS
236SOCIAL MEDIA IN ACADEMIC PULMONOLOGY : #PCCP2018 EXPERIENCE
237INHALER TECHNIQUE TRAINING FOR PATIENTS WITH RESPIRATORY DISEASES, SUPPORTED BY REHABILITATION THERAPISTS
237QUALITY ASSESSMENT OF CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY DISEASES IN CHINA IN 2017
238CATAMENIAL PNEUMOTHORAX IN THREE FILIPINO FEMALES: A CASE SERIES
238FEATURES OF RADIOLOGIC DIAGNOSTICS OF RESPIRATORY CYSTIC FIBROSIS FIRST DIAGNOSED IN ADOLESCENCE
238CORRELATION OF FORCED EXPIRATORY FLOW (FEF) 25–75% AND THE NUMBER OF PACK-YEARS AMONG SMOKERS
239CHANGES IN CD4+CD25+FOXP3+ TREG CELLS AND INF-γ BETWEEN SUBLINGUAL AND SUBCUTANEOUS IMMUNOTHERAPY WITH HOUSE DUST MITE IN CHINESE PATIENTS WITH ALLERGIC RHINITIS
COPD 2
239CONSUMER-LED BETTER BREATHING SUPPORT GROUPS - A HEALTH AND SOCIAL ENTERPRISE
240AN ACTION PLAN FOR SELF-MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN Republic of Korea
240PREDICTIVE VALUE OF COMBINING RAPID DECLINE OF FEV1 AND INFLAMMATORY BIOMARKERS FOR DEVELOPING COPD-A PROSPECTIVE COHORT STUDY IN BEIJING
240CLINICAL CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS DETECTED WITH COPD SCREENING IN THREE DIFFERENT RURAL AREAS IN JAPAN
241IMPAIRED SKELETAL MUSCLE OXYGENATION IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
241LOWER SERUM IMMUNOGLOBULIN FREE LIGHT CHAIN PREDICTS EXACERBATION RISK IN PATIENTS WITH COPD
241INHALED STEROIDS AND RISK OF PNEUMONIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
242PATTERN OF PATIENTS DIAGNOSED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN A MEDICAL CENTER, TAIWAN, FROM 2006 TO 2017
242CLINICAL USEFULNESS OF ONCE-DAILY TRIPLE THERAPY, CICLESONIDE AND TIOTROPIUM BROMIDE / OLODATEROL COMBINATION INHALER FOR COPD PATIENTS (2ND REPORT)
242THE IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE DURING HOSPITALIZATION
243THE LONG-TERM EFFICACY OF DOMICILIARY NON-INVASIVE POSITIVE PRESSURE VENTILATION IN COPD: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
243THE INTERPRETATION OF RESPIRATORY SYSTEM IMPEDANCE IN THE EARLY EXPIRATORY PHASE MEASURED BY FORCED OSCILLATION TECHNIQUE
243COULD PROBIOTICS USEFUL FOR COPD PATIENTS? AN EBM VIEW
244THE PREVALENCE OF VOIDING DYSFUNCTION AND THE EFFECT OF BRONCHODILATOR IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
244LONG-TERM COURSE OF EMPHYSEMA WITHOUT AIRFLOW LIMITATION
244PEDOMETER AS A TOOL FOR QUALITY OF LIFE IMPROVEMENT IN COPD PATIENTS
245COMPARISON OF CLINICAL CHARACTERISTICS AND INCIDENCE OF ACUTE EXACERBATION IN PATIENTS WITH ASTHMA-COPD OVERLAP AND COPD
245WHOLE GENOME DNA METHYLATION ANALYSIS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP IDENTIFIES NOVEL EPIGENETIC SIGNATURES
246COPD ASSESSMENT TEST (CAT) SCORE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON CLINICAL PHENOTYPES
246WHICH IS THE ADEQUATE TIMING? BLOOD EOSINOPHIL COUNT IN PATIENTS WITH COPD EXACERBATION
246ACCURACY OF PEAK EXPIRATORY FLOW RATE: HEIGHT RATIO (PEFR/HT2) MEASURED BY PORTABLE DEVICE IN PREDICTING LOW FEV1/FVC IN PATIENTS UNDERGOING SPIROMETRY AT SANTO TOMAS HOSPITAL
247R-VALUE COMPREHENSIVE EVALUATION METHOD FOR THE EFFECT AND LONG-TERM INFLUENCE OF TIAOBU FEI-SHEN THERAPIES ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE RATS
247COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
248COMPARING THE DIFFERENT DIAGNOSTIC CRITERIA OF ASTHMA-COPD OVERLAP
248DIFFUSING CAPACITY OF THE LUNGS FOR CARBON MONOXIDE IS A PREDICTOR FOR EXERTIONAL DESATURATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
249THIS ABSTRACT HAS BEEN WITHDRAWN
249THE PROPORTION AND CLINICAL CHARACTERISTICS OF ASTHMA-COPD OVERLAP (ACO) IN TAIWAN: A CROSS-SECTIONAL STUDY
249THIS ABSTRACT HAS BEEN WITHDRAWN
249STUDY REGARDING THE CLINICAL EFFICACY OF AG NPP709 (SYNATURA®) IN PATIENTS WITH CHRONIC BRONCHITIS TYPE COPD
249EFFECTS OF PEDOMETER INTERVENTION ON DAILY PHYSICAL ACTIVITY AND QOL IN PATIENTS WITH COPD, INCLUDING ADDITIONAL ANALYSIS ON ACO
250PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED RISK FACTORS IN NORTH INDIA
250THIS ABSTRACT HAS BEEN WITHDRAWN
250SURVEY OF THE HEALTH-RELATED QUALITY-OF-LIFE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AND DISEASE-RELATED INDIRECT BURDENS
250THE VALUE OF ALLERGY SCREENING IN CHINESE ADULT PATIENTS WITH CHRONIC RESPIRATORY DISEASES
251LIFE EXPECTANCY AND EXPECTED YEARS OF LIFE LOST IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
251THE CORRELATION OF ABSOLUTE EOSINOPHIL COUNT IN STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN FILIPINO PATIENTS
252ENHANCING THE COMPETENCE OF NURSES IN COPD CARE
252STUDY ON CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DIFFERENT PHENOTYPES
253THIS ABSTRACT HAS BEEN WITHDRAWN
253CARDIOPULMONARY EXERCISE TEST IN EVALUATION OF FUNCTIONAL CAPACITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
253EOSINOPHILIC AIRWAY INFLAMMATION AND AIRWAY HYPERRESPONSIVENESS IN COPD
253THE APPLICATION OF INTELLIGENT WRISTBANDS IN THE ACUTE EXACERBATION OF COPD PATIENTS
254IMPACT OF SMOKING ON COPD DEATH IN TAIWAN AND FORECASTING MORTALITY TO 2025
254DIRECT AND INDIRECT COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN KOREA
254QT INTERVAL AS A PREDICTOR FOR THE SEVERITY AND PROGRESSION AMONG COPD PATIENTS
255FENO CONCENTRATION DISTRIBUTION IN COPD PATIENTS
255PREVALENCE AND PREDICTOR FACTORS INFLUENCE OVERLAP SYNDROME AMONG COPD PATIENTS IN DR CIPTO MANGUNKUSUMO HOSPITAL JAKARTA: A CROSS SECTIONAL STUDY
CRITICAL CARE MEDICINE 2
255MAJOR ADVERSE CARDIOVASCULAR EVENTS AND GASTROINTESTINAL BLEEDING DURING SEPSIS AND THEIR IMPACTS ON HOSPITALIZATION OUTCOMES
256ELECTRICAL IMPEDANCE TOMOGRAPHY AND RESPIRATORY MECHANICS CHANGE IN TWEEN LAVAGE INDUCED ACUTE LUNG INJURY PORCINE MODEL
256PROPORTIONAL ASSIST VENTILATION AS A MODE OF WEANING IN ADULT PATIENTS REQUIRING MECHANICAL VENTILATION: A META-ANALYSIS
257COMPARING INDIRECT CALORIMETRY AND ESTIMATING ENERGY EQUATIONS TO EXPLORE THE ENERGY EXPENDITURE IN BILATERAL LUNG TRANSPLANT PATIENTS
257THE COMPARISON OF SURGICAL AND MEDICAL PATIENTS EXPERIENCED UNPLANNED EXTUBATION
257USEFULNESS OF NON-INVASIVE POSITIVE-PRESSURE VENTILATION DELIVERED BY HELMET VS FACIAL MASK IN PATIENTS WITH POST-EXTUBATIONAL RESPIRATORY DISTRESS
258DIFFERENT CHARACTERISTIC PATTERN IN ICU SEPTIC PATIENTS DUE TO PNEUMONIA OR NON-PNEUMONIA
258BODY MASS INDEX (BMI) CAN HELP PREDICT IMMUNE STATUS AND SHORT-TERM SURVIVAL IN PATIENTS WITH SEPSIS ADMITTED TO ICU
258GENOTYPIC CHARACTERISTICS OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN PATIENTS WITH SEPSIS
259CROSS-CULTURAL ADAPTATION AND PSYCHOMETRIC TESTING OF A CHINESE VERSION OF RESPIRATORY DISTRESS OBSERVATION SCALE
259HYPERNATREMIA IN CRITICALLY ILL SEPSIS PATIENTS: A PROPENSITY SCORE ANALYSIS
259TIME TO LUNG VOLUME RECOVERY AFTER SUCTIONING PREDICTS LUNG COLLAPSE AFTER PEEP DECREMENT IN RECOVERING ARDS PATIENTS
260REVERSE TRIGGERING IN A PATIENT WITH CRYPTOCOCCAL MENINGITIS COMPLICATED WITH CEREBELLAR TONSILLAR HERNIATION
260PROTECTIVE EFFECTS OF RAMELTEON ON ACUTE LUNG INJURY -INDUCED BY VENTILATOR IN A RAT MODEL
261FLUID BALANCE IS ASSOCIATED WITH MULTI-ORGAN DYSFUNCTION SYNDROME IN PATIENTS WITH SEPTIC SHOCK IN THE ICU
261BALANCED CRYSTALLOIDS VS NORMAL SALINE SOLUTION AS INTRAVENOUS FLUID THERAPY AMONG CRITICALLY ILL PATIENTS: A META-ANALYSIS
261RELATIONSHIP OF RETINOPATHY OF PREMATURITY WITH AEROSOL THERAPY IN MECHANICALLY VENTILATED PRETERM INFANTS
262DM SEPTIC PATIENTS ARE ASSOCIATED WITH IMPAIRED IMMUNE RESPONSE BUT NOT POOR SURVIVAL IN ICU
262CASE REPORT: BILATERAL PNEUMOTORAKS OF CATAMENIAL PNEUMOTHORAX WITH MULTIPLE BULLAE
262CLINICAL OUTCOMES IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN VIETNAM ACCORDING TO SEVERITY OF THE BERLIN DEFINITION
262A STUDY ON THE PREDICTION OF DEATH IN ICU PATIENTS USING CRRT
263ACUTE HYPERGLYCEMIA AGGRAVATES ACUTE LUNG INJURY VIA ACTIVATION OF SODIUM–POTASSIUM–CHLORIDE COTRANSPORTER 1
263FACTORS AFFECTING FAMILIES' PERCEPTION ABOUT THE PROCESS OF DECISION TO FORGO LIFE-SUSTAINING TREATMENTS
263HIGH PEAKED AIRWAY PRESSURES FROM A KINKED ENDOTRACHEAL TUBE
264THE MORTALITY RATE OF PRONE POSITION COMPARED WITH SUPINE POSITION FOR TREATING ARDS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
264THE MORTALITY RATE OF LUNG RECRUITMENT MANEUVERS IN ARDS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
264DOES MECHANICAL VENTILATION HAVE ANY ROLE IN AFFECTING SLEEP ARCHITECTURE IN CRITICALLY ILL PATIENTS?
265EFFECTS OF DRIVING PRESSURE TO MORTALITY IN PATIENTS WITH SEVERE ARDS WHO RECEIVING PRONE POSITION
ENVIRONMENTAL & OCCUPATIONAL HEALTH AND EPIDEMIOLOGY 2
265THE CIR-008885/MIR-30C/LRRC8D AXIS ENHANCES THE MACROPHAGEACTIVATION INDUCED BY SILICA
266ASSESSMENT OF THE PATHOPHYSIOLOGICAL SIZE RANGES OF AIR MICROSUSPENSIONS CAUSING DEVELOPMENT AND PROGRESSION OF RESPIRATORY DISEASES
266PULMONARY TOXICITY OF CROSS-LINKED SOLUBLE POLYACRYLATE FOLLOWING INTRATRACHEAL INSTILLATION
266EFFICACY AND SAFETY OF VERNONIA CINEREA PASTILLES FOR SMOKING CESSATION
267SURVEY ON RESPIRATORY DISORDERS IN PRESCHOOL CHILDREN PRE AND POST ADMISSION TO PRESCHOOLS IN KANDY, CENTRAL SRI LANKA
267SURVEY OF RESPIRATORY SYMPTOMS AMONG PRESCHOOL CHILDREN IN RESPONSE TO DOMESTIC TRIGGERS IN KANDY, CENTRAL SRI LANKA
267OCCUPATIONAL LUNG CANCER: EXPERIENCE IN A MEDICAL CENTER IN SOUTHERN TAIWAN
268EFFECTS OF TUNGSTEN OXIDE ON LUNGS FOLLOWING INHALATION
268ANALYSIS OF CLINICAL FEATURES IN PATIENTS WITH PNEUMOCONIOSIS COMPLICATED WITH PULMONARY EMPHYSEMA
268THE LEVEL AND DYNAMICS OF RESPIRATORY DISEASES MORBIDITY IN RUSSIA
269COMPARISON OF OCCUPATIONAL EXPOSURE LIMITS OF CHEMICAL SUBSTANCES IN WORKPLACE BETWEEN CHINA GBZ 2.1 AND GERMAN MAK
269SURVEY ON RESPIRATORY SYMPTOMS OF URBAN VS RURAL PRESCHOOL CHILDREN IN KANDY, CENTRAL SRI LANKA
269A THERAPEUTIC METHOD FOR PM2.5-INDUCED LUNG INJURY BASED ON EXOSOME IN RATS
270OBSTRUCTIVE AIRWAY DISEASE IN TRIBAL AND NON-TRIBAL POPULATIONS IN RURAL BENGAL, INDIA
INTERSTITIAL LUNG DISEASE 2
270THE USE OF KETOCONAZOLE FOR THE TREATMENT OF REFRACTORY HYPERCALCAEMIA IN SARCOIDOSIS
271SYMPTOMS OF INTERSTITIAL LUNG DISEASE THAT AFFECT QUALITY OF LIFE
271CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES COMPARED TO CONNECTIVE TISSUE DISEASE RELATED-INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
272CLINICAL ANALYSIS OF THE CASES OF INTERSTITIAL PNEUMONIA COMBINED WITH MALIGNANT TUMOR ASSOCIATED WITH POLYMYOSITIS AND DERMATOMYOSITIS IN OUR HOSPITAL
272PREVALENCE OF ANXIETY AND DEPRESSION AS WELL AS ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL LUNG DISEASE
272CLINICAL PROGNOSIS OF ACUTE EXACERBATION OF COMBINED PULMONARY FIBROSIS AND EMPHYSEMA
272PATTERN OF INTERSTITIAL LUNG DISEASES IN A SINGLE CENTER OF SRI LANKA
273THE SERUM KL-6 LEVELS IN UNTREATED IDIOPATHIC PULMONARY FIBROSIS CAN NATURALLY DECLINE IN ASSOCIATION WITH DISEASE PROGRESSION
273EFFICACY AND SAFETY ANALYSIS OF THE WHOLE LUNG LAVAGE IN TREATMENT OF PULMONARY ALVEOLAR PROTEINOSIS
274B CELL ACTIVATING FACTORS IN PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS
274THE CHRONOLOGY OF PULMONARY AND CUTANEOUS MANIFESTATIONS IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE PATIENTS: A CASE SERIES
274MULTIPLE CYSTS FORMATION IN PULMONARY LUNG CHAIN DEPOSITION DISEASE (LCDD). A CASE REPORT
274PULMONARY ALVEOLAR PROTEINOSIS WITH UPPER-LOBE PREDOMINANCE IN A NON-SMOKING YOUNG FEMALE
275IMPACT OF PHYSICAL ACTIVITY PRIOR TO AND AFTER ANTIFIBROSIS THERAPY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
275HISTONE DEACETYLASE 3 INDUCES ALVEOLAR EPITHELIAL-MESENCHYMAL TRANSITION UNDER HYPOXIC CONDITION
276CLINICAL SIGNIFICANCE OF FERRITIN LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH ANTI-AMINOACYL-TRNA SYNTHETASE ANTIBODY-POSITIVE INTERSTITIAL LUNG DISEASE
276AN EXPERT QUESTIONNAIRE ANALYSIS FOR DEVELOPING IDIOPATHIC PULMONARY FIBROSIS PATIENT-REPORTED OUTCOME SCALE
276IDIOPATHIC PULMONARY FIBROSIS IS A POSSIBLE RISK FACTOR FOR OSTEOPOROSIS
277AN EXPERIENCE OF PULMONARY REHABILITATION IN A PATIENT WITH COMBINED PULMONARY FIBROSIS AND EMPHYSEMA: A CASE REPORT
277ANALYSIS OF CLINICAL FEATURES AND COUGH CHARACTERISTICS OF PATIENTS WITH INTERSTITIAL LUNG DISEASE
277ACUTE EXACERBATION OF PLEUROPARENCHYMAL FIBROELASTOSIS IN PATIENT STATUS POST HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT
278CLINICAL ANALYSIS OF 45 DIABETIC PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
278INTERVAL OF PREVIOUS X-RAY EXAMINATION IN ADVANCED LUNG CANCER WITH INTERSTITIAL PNEUMONIA
278THE EXPRESSION AND SIGNIFICANCE OF P-ERK1/2, FGF2, FGFR2 IN IDIOPATHIC PULMONARY FIBROSIS AND NON-SMALL CELL LUNG CANCER
279HUMIDIFIER LUNG: CHARACTERIZATION OF FEATURES AND COMPARISON TO OTHER HYPERSENSITIVITY PNEUMONITIS PHENOTYPES
279A RARE CASE OF SARCOIDOSIS-TUBERCULOSIS MASQUERADING AS MALIGNANCY WITH GALAXY SIGN AND HYPERCALCAEMIA
279COMBINED MARKER ASSAY, NOT THE VALUE OF A SINGLE KL-6 IN EARLY DIAGNOSIS OF IPF
280DRUG-INDUCED LUNG INJURY DUE TO BEPRIDIL WITH POSITIVE DLST AFTER SPONTANEOUS IMPROVEMENT IN CLINICAL FEATURES
LUNG CANCER 2
280THERAPEUTIC OUTCOMES IN PATIENTS WITH CT1MI-CN0M0 LUNG CANCER DOMINANT WITH GROUND GLASS OPACITY TREATED BY CARBON ION RADIOTHERAPY
281THE ROLE OF PATIENT'S SELF-REPORTED HEALTH-RELATED QUALITY OF LIFE AS A PREDICTOR OF OVERALL SURVIVAL IN ADVANCED NON-SMALL CELL LUNG CANCER WITH AGE OVER 75
281CLINICAL CORRELATION BETWEEN PREOPERATIVE SERUM OXIDATIVE STRESS LEVEL AND ABERRANT DNA METHYLATION IN PERIPHERAL BLOOD OF PATIENTS WITH STAGE I LUNG ADENOCARCINOMA; A PILOT ANALYSIS
282A STUDY OF CASES WITH POSTOPERATIVE RECURRENT LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS
282GENETIC VARIANTS IN THE TNF/TNFR SIGNALING PATHWAY GENES ARE ASSOCIATED WITH SURVIVAL OF NONSMALL-CELL LUNG CANCER PATIENTS
282IMPROVED TREATMENT OUTCOME OF PEMBROLIZUMAB IN NSCLC PATIENTS WITH COPD
283ONCOGENIC AND IMMUNE PATHWAYS CORRELATED WITH MOLECULAR PROGNOSTIC MARKER SIALYLTRANSFERASE ST3GAL3 IN NON-SMALL CELL LUNG CANCER
283THE EFFECT OF EGFR MUTATION TO METASTASIS IN STAGE III-IVB LUNG ADENOCARCINOMA
284FIRST GENERATION EGFR-TKIS COMPARISON IN NON-SMALL CELL LUNG CANCER PATIENTS HARBOURING SENSITIVE EGFR MUTATIONS
284PEMBROLIZUMAB AS THE FIRST THERAPY FOR SYNCHRONOUS DOUBLE CANCER OF LUNG CANCER AND GASTRIC CANCER. A CASE REPORT
285PREVENTING AND TREATING BRAIN METASTASES WITH THREE FIRST-LINE EGFR-TYROSINE KINASE INHIBITORS IN PATIENTS WITH EGFR MUTATION-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER
285A CASE OF PRIMARY PULMONARY MONOPHASIC SYNOVIAL SARCOMA
286EFFICACY OF SALVAGE CHEMOTHERAPY AFTER IMMUNE CHECKPOINT INHIBITOR IN NON-SMALL CELL LUNG CANCER PATIENTS
286THE EGFR MUTATION PATTERN AFTER EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS THERAPY IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER HARBOURING ACTIVATING UNCOMMON EGFR MUTATIONS
286DIABETES IS ASSOCIATED WITH THE RISK OF PROGRESSION AND PROGNOSIS IN LUNG CANCER
287PRIMARY THYMIC MALIGNANT LYMPHOMA SUSPECTED OF THYMOMA: A REPORT OF TWO CASES
287ESTABLISHMENT OF PRIMARY PATIENT-DERIVED CANCER CELLS OF LUNG CANCER
287AN AUTOPSY CASE OF RUPTURED LIVER METASTASES FROM SMALL CELL LUNG CANCER: CASE REPORT AND LITERATURE REVIEW
288DIFFERENCES IN SMALL CELL LUNG CANCER GENETIC PROFILE BETWEEN DISEASE PROGRESSION (PD) AND PARTIAL REMISSION (PR) PATIENTS AFTER THE STANDARD FIRST-LINE CHEMOTHERAPY
288ANALYSIS OF ADVANCED OR POSTOPERATIVE RECURRENT NON-SMALL CELL LUNG CANCER CASES TREATED WITH NIVOLUMAB AT HOSPITALS IN NAGASAKI, JAPAN
288FACTORS ASSOCIATED WITH CRIZOTINIB EFFICACY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING DIFFERENT ALK FUSION VARIANTS
289A CASE OF THYMIC CARCINOMA FOUND IN MARIE-BAMBERGER SYNDROME
289LIPID DROPLETS SUPPORT THE CELL GROWTH AND PROLIFERATION AND ALLEVIATE THE STARVATION INDUCED CELL DEATH IN THE LUNG CANCER CELLS
289THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER
290PRIMING OF ANTI-PD-1/ PD-L1 THERAPY BY ANTI-METABOLITE CHEMOTHERAPEUTIC AGENTS IN NSCLC
290THE RELATIONSHIP OF MELANO–ASSOCIATED ANTIGEN (MAGE) A3 EXPRESSION AND BRONCHOALVEOLAR LAVAGE (BAL) CYTOLOGICAL RESULTS NSCLS AT DR SOETOMO REGIONAL HOSPITAL OF SURABAYA
290APSR MEMBERSHIP SURVEY OF EGFR MOLECULAR TESTING OF NSCLC IN THE ASIA-PACIFIC REGION
291INCIDENCE OF HEPATITIS B REACTIVATION DURING EGFR TYROSINE KINASE INHIBITORS TREATMENT IN NON-SMALL-CELL LUNG CANCER PATIENTS
291SOMATIC GENE MUTATIONS IN PATIENTS WITH ADENOSQUAMOUS CELL CARCINOMA OF THE LUNG
291CLINICAL PERSPECTIVES ON THE UNCOMMON EGFR P.L747P AND P.L747S MUTATIONS IN LUNG ADENOCARCINOMA: A CASE SERIES STUDY
292RISK FACTORS FOR DISSEMINATED INTRAVASCULAR COAGULATION (DIC) IN PATIENTS WITH LUNG CANCER
292THE SURVIVAL ANALYSIS OF INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER WITH THE FIRST-LINE THERAPY IN SOUTHERN OF TAIWAN
293RBM10 INHIBITS PROLIFERATION OF LUNG ADENOCARCINOMA VIA RAP1A-AKT-CREB SIGNALING PATHWAY
293FIRST-LINE GEFITINIB, ERLOTINIB, AND AFATINIB PROVIDED SIMILAR CLINICAL EFFICACY IN PATIENTS WHO HAD STAGE IV LUNG ADENOCARCINOMA HARBORING RARE EGFR MUTATION IN TAIWAN
293A CASE REPORT ON LUNG ADENOCARCINOMA IN A PREGNANT PATIENT
2931-YEAR SURVIVAL OF NON-SMALL CELLS LUNG CARCINOMA (NSCLC) PATIENTS AND INFLUENCING FACTORS
294PATIENTS WHO DEVELOP FEBRILE NEUTROPENIA (FN) IN THE INITIAL REGIMEN IN PATIENTS WITH SMALL CELL LUNG CANCER(SCLC) HAVE A POOR PROGNOSIS
294PINK1 REGULATES PD-L1 AND MHC-I EXPRESSION IN LUNG CANCER WITH GLYCOLYTIC PHENOTYPE
294RISK FACTORS ASSOCIATED WITH THE OCCURRENCE OF LUNG CANCER IN WOMEN IN PERSAHABATAN HOSPITAL, JAKARTA
295REAL-WORLD CLINICAL OUTCOMES AND PATHOLOGIC FEATURES OF BRAF V600E-MUTATED LUNG ADENOCARCINOMA PATIENTS IN TAIWAN
295PRIMARY ATYPICAL NEUROENDOCRINE TUMOR OF THE THYMUS: A CASE REPORT
296ANALYSIS OF INVASIVE RISK FACTORS FOR PURE SUB-CENTIMETER GROUND-GLASS NODULES
296EFFECTS OF RODENT TUBER EXTRACT CAPSULES (TYPHONIUM FLAGELLIFORME) INPATIENTS WITH LUNG CANCER WHO REFUSED CHEMOTHERAPY
296TREATMENT OF NON-SMALL CELL LUNG CANCER WITH ATEZOLIZUMAB: A CASE SERIES STUDY
297ORAL VINORELBINE AND CISPLATIN PLUS CONCOMITANT CHEMO-RADIOTHERAPY AS INDUCTION THERAPY IN STAGE III NON-SMALL CELL LUNG CARCINOMA: RESULTS OF A MULTI-CENTER PHASE II TIAL
297STUDY OF COMPARISON AMONG DIAGNOSTIC MODALITIES TO ESTABLISH THE DIAGNOSIS OF LUNG CANCER : CEA MARKER, CT-SCAN IMAGING, AND BRONCHOSCOPIC METHOD
297REAL-WORLD FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN TAIWAN: A POPULATION-BASED RETROSPECTIVE STUDY
PAEDIATRIC LUNG DISEASE 2
298ASSOCIATION BETWEEN PNEUMONIA IN PRETERM INFANTS AND GENITAL MYCOPLASMAS IN PLACENTAS
298THE AVAILABILITY OF VITAMIN D TO THE AMUR REGION CHILDREN AND ADOLESCENTS WITH PATHOLOGY OF THE LUNGS
299INVESTIGATION ON THE RELATION BETWEEN CHRONIC COUGH AND MYCOPLASMA PNEUMONIA CHLAMYDIA PNEUMONIA INFECTION IN CHILDREN
299CURATIVE OBSERVATION ON CHILDREN WITH MYCOPLASMA PNEUMONIA TREATED BY AZITHROMYCIN AND HUMAN- R- GLOBULIN
299PULMONARY SEQUESTRATION: AN UNUSUAL CAUSE OF RESPIRATORY DISTRESS IN A NEWBORN
299OUTBREAK OF HUMAN METAPNEUMOVIRUS INFECTION OF CHILDREN IN BUSAN, Republic of Korea
300A TEN YEARS OLD GIRL PRESENTED WITH JIA INDUCED ILD
PULMONARY CIRCULATION 2
300RATIONAL AND DESIGN OF THE LARGEST PROSPECTIVE MULTICENTER REGISTRY STUDY ON PULMONARY EMBOLISM IN CHINA: THE CURES STUDY
300HYDROGEN GAS INHALATION IS A NOVEL TREATMENT FOR PULMONARY HYPERTENSION
301A CASE OF PULMONARY EMBOLISM FROM SUPERFICIAL VENOUS THROMBOSIS WITH AN UPPER EXTREMITY SOURCE IN A 35-YEAR-OLD FEMALE ON ORAL CONTRACEPTIVE PILLS
301GENETIC VARIANT OF CYP4V2 ASSOCIATED WITH VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
301ACUPUNCTURE INDUCED PULMONARY THROMBOEMBOLISM AND DEEP VEIN THROMOBOSIS: A CASE REPORT
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2
302THE CLINICAL FEATURES ANALYSIS OF TRACHEOBRONCHIAL FUNGAL INFECTIONS WITH TUMOR-LIKE LESION
302PROSPECTIVE INVESTIGATION OF ELDERLY NON-TUBERCULOUS MYCOBACTERIA (NTM) LUNG DISEASE: THE ACTUAL TREATMENT AND THE PROGNOSIS IN CLINICAL SETTING
302JOB'S SYNDROME: RECURRENT PULMONARY INFECTIONS IN PRIMARY IMMUNODEFICIENCY, A CASE REPORT
303PROGNOSIS OF PATIENT WITH BRONCHIECTASIS AFTER HOSPITALIZED EXACERBATION
303GENOTYPIC CHARACTERISTICS OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAEIN ONE OF SECONDARY REFERRAL HOSPITAL IN Republic of Korea
304THE LIMITED IMPACT OF PSYCHIATRIC DISEASE AND PSYCHOTROPHIC MEDICATION ON THE OUTCOME OF HOSPITALIZATION FOR PNEUMONIA
304PREDICTORS OF 30 DAYS MORTALITY AMONG COMMUNITY-ACQUIRED PNEUMONIA PATIENTS WITH COMORBIDITY IN TERTIARY CARE HOSPITAL
304MALNUTRITION ALTERS PERFORMANCE STATUS OF ELDERLY PATIENTS WITH PARAPNEUMONIC EFFUSION
305A CASE REPORT: THE COEXISTENCE OF PULMONARY CRYPTOCOCCOSIS AND GRANULOMATOSIS WITH POLYANGIITIS
305QUICK SOFA AND PERFORMANCE STATUS SCORING SYSTEMS PREDICT THE PROGNOSIS OF PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA
305IMPLEMENTING A CARE BUNDLE APPROACH REDUCES DURATION OF LENGTH OF STAY IN COMMUNITY-ACQUIRED PNEUMONIA
306LONG-TERM OBSERVATION OF ANTI–GLYCOPEPTIDOLIPID-CORE ANTIBODY TITER IN PATIENTS WITH MYCOBACTERIUM AVIUMCOMPLEX–POSITIVE LUNG DISEASE
306SMALL COHORT RETROSPECTIVE STUDY MIXED CO-INFECTION OF FUNGUS IN PNEUMINA POPULATION
306CANDIDAL TRACHEOBRONCHITIS AFTER TOTAL AORTIC REPLACEMENT AND THORACIC ENDOVASCULAR AORTIC REPAIR
307PNEUMOCOCCAL URINARY ANTIGEN TEST USE AS A PROGNOSTIC MARKER IN PATIENTS ADMITTED WITH COMMUNITY-ACQUIRED PNEUMONIA: A PROPENSITY SCORE MATCHING STUDY
307ONE CASE OF PNEUMOCONIOSIS ASSOCIATED WITH PULMONARY NOSOCOMIAL INFECTION
307THREE CASES OF POM-1 METALLO-β-LACTAMASE PRODUCING PSEUDOMONAS OTITIDIS ISOLATED FROM RESPIRATORY SPECIMENS
308INCIDENCE AND CLINICAL FEATURES OF COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY MACROLIDE-RESISTANT MYCOPLASMA PNEUMONIAE FROM ADULTS IN JEJU
308ADVANCES IN ESTABLISHMENT OF BRONCHIECTASIS ANIMAL MODEL
308IS BLOOD CULTURE USEFUL IN THE MANAGEMENT OF ASPIRATION PNEUMONIA?
309ORGANIZATION AND CLINIC-EPIDEMIOLOGIC ASSESSMENT OF EFFICIENCY OF THE REGIONAL PROGRAM OF RESPIRATORY INFECTIONS PREVENTION
309PULMONARY INFECTION CAUSED BY NOCARDIA FARCINICA IN AN IMMUNOCOMPETENT PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE
309NATURAL HISTORY OF NON-CAVITARY NODULAR BRONCHIECTATIC MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE
309MICROBIOLOGICAL PATTERN OF PULMONARY INFECTION PATIENTS IN PERSAHABATAN HOSPITAL INTESIVE CARE UNIT AND IT'S CORRELATION WITH SEVERITY OF THE DISEASE MEASURE WITH APACHE II SCORE
310THIS ABSTRACT HAS BEEN WITHDRAWN
310ANALYSIS FOR DISTRIBUTION RANGE AND DRUG RESISTANCE OF PATHOGENIC BACTERIA IN SPUTUM OF AECOPD INPATIENTS
310DISSEMINATED MYCOBACTERIUM KANSASII DISEASE IN A PATIENT WITHOUT A DIAGNOSIS OF CLINICAL IMMUNODEFICIENCY
310LEGIONELLA PNEUMONIA INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME: CASE SERIES OF A TERTIARY MEDICAL CENTER IN TAIWAN
311IATROGENIC PLEURAL EMPYEMA CAUSED BY PROPIONIBACTERIUM ACNES
311COMPARISON OF GROCOTT-GOMORI METHENAMINE SILVER AND IMMUNOFLUORESCENCE STAINING FOR DIAGNOSING PNEUMOCYSTIS PNEUMONIA: ANALYSIS INVOLVING QUANTITATIVE PCR FOR DETECTION OF PNEUMOCYSTIS JIROVECII IN BRONCHOALVEOLAR LAVAGE FLUID
RESPIRATORY NEUROBIOLOGY AND SLEEP 2
311DIFFERENT PROFILES OF COUGH HYPERSENSITIVITY MEDIATED BY TRPV1, TRPA1 IN PATIENTS WITH CHRONIC REFRACTORY COUGH
312MOTOR UNIT RECRUITMENT IN HUMAN GENIOGLOSSUS DURING FLOW-LIMITED BREATHING IN SLEEP
312THE HMGB1-RAGE/TLR-TNF-α SIGNALING PATHWAY MAY CONTRIBUTE TO KIDNEY INJURY INDUCED BY HYPOXIA
312COMBINATION OF NON CPAP THERAPY IN PATIENTS WITH OSA
313A RETROSPECTIVE ANALYSIS ON THE DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS PRESENTING TO THE SLEEP MEDICINE CLINIC HOSPITAL TAIPING
313GETTING OLDER IS ASSOCIATED WITH THE INCREASED RISK FOR OSA AND HYPOVENTILATION IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
314NORADRENERGIC A7 CELL GROUP MODULATES THE CENTRAL REGULATION OF GENIOGLOSSUSIN RATS
314A PREDICTION EQUATION OF OPTIMAL CPAP PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN MALAYSIA
314SLEEP EFFICIENCY AND NOCTURNAL DESATURATION ASSOCIATED WITH HYPERTENSION
315EPIDEMIOLOGICAL CHARACTERISTIC OF ISCHEMIC STROKE IN ADULTS INDONESIAN OBSTRUCTIVE SLEEP APNEA POPULATION: A PRELIMINARY STUDY
RESPIRATORY STRUCTURE AND FUNCTION 2
315EFFECT OF MODERATE ENDURANCE TRAINING ON EXERCISE BIOLOGICAL CALIBRATION
316EFFECTS OF DIFFERENT-INTENSITY INSPIRATORY MUSCLE TRAINING ON DIAPHRAGM AND ASSISTIVE INSPIRATORY MUSCLE THICKNESS IN HEALTHY INDIVIDUALS
316RIGHT UNILATERAL PULMONARY APLASIA: A CASE REPORT
316THE EFFECTS OF SCAPULA AND TRUNK MUSCLE TRAINING ON MOUTH PRESSURE
317SWOT ANALYSIS ON THE PROMOTION OF PULMONARY FUNCTION TEST IN PRIMARY MEDICAL AND HEALTH SERVICE INSTITUTIONS
317DIFFERENCES BETWEEN THIRACIC AND ABDOMINAL RESPIRATION IN MOSTGRAPH ANALYSIS
317A 6-WEEK OLD INFANT WITH FIRST EPISODE OF COUGH DIAGNOSED WITH BRONCHUS SUIS: A CASE REPORT
318SHORT-TERM INSPIRATORY MUSCLE TRAINING IN HOSPITALIZED HEART FAILURE PATIENTS IS SAFE AND EFFECTIVE FOR IMPROVING INSPIRATORY MUSCLE STRENGTH AND DYSPNOEA ON EXERTION
318DECREASED LUNG FUNCTION IS ASSOCIATED WITH INCREASED RISK OF DEVELOPING NON-ALCOHOLIC FATTY LIVER DISEASE: A LONGITUDINAL COHORT STUDY
TUBERCULOSIS 2
318ANALYSIS OF AGE-SPECIFIC BACKGROUND OF ACTIVE TUBERCULOSIS IN AIZU MEDICAL CENTER, JAPAN
319REDUCING TUBERCULOSIS BUT CONTRACTING SHINGLES IN PATIENTS WITH TYPE 2 DIABETES RECEIVING STATIN VS NONSTATIN LIPID LOWERING AGENTS
319INCIDENCE OF ACTIVE TUBERCULOSIS WITHIN 1 YEAR AFTER TUMOR NECROSIS FACTOR INHIBITOR TREATMENT ACCORDING TO LTBI STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
319DECREASED MIR-150-5P EXPRESSION IN PATIENTS WITH ACTIVE PULMONARY TUBERCULOSIS (TB) DISEASE
320CORRELATION BETWEEN MATRIX METALLOPROTEINASE-9 AND THE SEVERITY DEGREE OF CHEST X-RAY IN PULMONARY TUBERCULOSIS PATIENTS
320DIFFERENTIATION BETWEEN LYMPHOMA ASSOCIATED EFFUSIONS AND TUBERCULOUS PLEURAL EFFUSION
320ANALYSIS OF TB SURVEILLANCE DATA ON FOREIGN-BORN PERSONS "TRANSFERRING OUT" IN JAPAN - IMPLICATIONS FOR CROSS-BORDER COLLABORATION FOR TB CARE AND PREVENTION
321THE ROLE OF SURGERY FOR THE TREATMENT OF INCIDENTAL PULMONARY TUBERCULOSIS FINDING IN A TUBERCULOSIS-ENDEMIC COUNTRY
321THE GREAT MIMICKER: PULMONARY TUBERCULOSIS WITH AXILLARY MASS
322A RARE CASE OF ANTERIOR MEDIASTINAL MASS IN A 12 MONTH OLD: TUBERCULOSIS
322VITAMIN D, SERUM IL-15 AND SERUM IP-10 ARE POTENTIAL BIOMARKERS TO DIFFERENTIATE ACTIVE TB AND LATENT TB
323RISK FACTORS OF TIME ADVERSE EFFECTS OF KANAMISIN ON TUBERCULOSIS DRUG RESISTANT
323THE GREAT MASQUERADER: A CASE REPORT ON PULMONARY TUBERCULOSIS AND LUNG CANCER
323'TENNIS RACKET' SIGN: AN OBLIVION PREDICTOR OF ACTIVE TUBERCULOSIS
323ANALYSIS OF AGE-SPECIFIC CT FINDINGS OF ACTIVE TUBERCULOSIS IN AIZU MEDICAL CENTER, JAPAN
324KNOWLEDGE, ATTITUDES AND BEHAVIOUR PATIENT SUSPECT MDR-TB AT PULMONARY HEALTH CENTER (BKPM) IN MALUKU-INDONESIA
324CLINICAL FACTORS ASSOCIATED WITH INITIATION OF LTBI TREATMENT AMONG HEALTH CARE WORKERS IN A REFERRAL HOSPITAL IN KOREA
324SPECTRUM OF TUBERCULOSIS IN ADVANCED CHRONIC KIDNEY DISEASE (ACKD)
325PULMONARY TUBERCULOSIS IN ADVANCED CHRONIC KIDNEY DISEASE; A DESCRIPTIVE STUDY ON DISEASE PATTERN AND TREATMENT OUTCOME IN A HIGH CKD PREVALENT SETTING
326THE IMPORTANT OF RAPID MOLECULAR TEST IN TB DIAGNOSIS AND PROMPT TREATMENT
326THE TREND OF TUBERCULOSIS RESEARCH IN NORTH KOREA BASED ON A REVIEW OF LITERATURE
326A FILIPINO WITH MULTIPLE SACCULAR ANEURYSMS CAUSED BY MYCOBACTERIUM TUBERCULOSIS
327THE INFLUENCE OF COMPLICATION OF INTERSTITIAL LUNG DISEASE TO MORTALITY AND LENGTH OF STAY IN WARD FOR THE PATIENTS WITH PULMONARY TUBERCULOSIS
327DIAGNOSTIC DISCREPANCY, A DRUG SENSITIVE OR MDR-TB : CASE REPORT
327QUALITY OF LIFE OF PATIENTS WITH MULTI-DRUG RESISTANT TUBERCULOSIS AT PROGRAMMATIC MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS WESTERN VISAYAS MEDICAL CENTER JANUARY 2013 TO APRIL 2015 PHILIPPINES
327SUCCESSFUL DESENSITIZATION FOR ANTI-TUBERCULOSIS HYPERSENSITIVITY DRUG REACTION: A CASE SERIES
328ABDOMINAL TUBERCULOSIS MANAGED SURGICALLY IN THE LATE PHASE:A CASE REPORT
328LATENT TUBERCULOSIS INFECTION ON HEALTHCARE WORKER IN WEST SUMATERA PULMONARY HOSPITAL
CRITICAL CARE MEDICINE 2
328STATIN TREATMENT MAY PREVENT DEVELOPMENT OF ACTIVE TUBERCULOSIS IN DIABETIC STATE: AN ANALYSIS OF A NATIONALLY REPRESENTATIVE COHORT
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2
329THE DIAGNOSIS VALUE OF BRONCHOALVEOLAR LAVAGE DETECTION BY HIGH-THROUGHPUT SEQUENCING FOR PULMONARY INFECTIOUS DISEASES
329HOSPITAL-ACQUIRED PNEUMONIA RATE IN A HOSPITAL AFFILIATED UNIVERSITY IN CHINA: A CROSS-SECTIONAL SURVEY INVOLVING 210417 INPATIENTS
CRITICAL CARE MEDICINE 1
330INFLUENZA A PANDEMIC (H1N1) 2009 VIRUS INFECTION WITH DEATH LIMB EXTREMITIES INFERIOR AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS): A CASE REPORT
INTERSTITIAL LUNG DISEASE 1
330CLINICAL COURSES AND TREATMENT EFFECTS IN SYSTEMIC SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE
COPD 2
330PERCEPTION OF SYMPTOMS AND PATIENT'S VIEW IN COPD- MARKERS OF CHANGING NEEDS
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 1
331CHARACTERISTICS OF HOSPITAL-ACQUIRED PNEUMONIA PATIENTS WITH MULTIDRUG-RESISTANT BACTERIAL INFECTION IN DR CIPTO MANGUNKUSUMO GENERAL HOSPITAL INDONESIA
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2
331IDENTIFYING OF RISK FACTORS OF MULTI-DRUG RESISTANT BACTERIA IN HOSPITALIZED ACQUIRED PNEUMONIA
COPD 1
331ASSOCIATION OF SERUM URIC ACID LEVELS AND OUTCOMES OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PROSPECTIVE COHORT STUDY
LUNG CANCER 1
332A META-ANALYSIS ON INDWELLING PLEURAL CATHETERS VERSUS PLEURODESIS IN THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS: A MODERN DILEMMA
CRITICAL CARE MEDICINE 2
332ACCURACY OF GAS EXCHANGE MEASUREMENTS AS PREDICTORS OF EARLY SUCCESSFUL WEANING AMONG ICU PATIENTS OF PHILIPPINE HEART CENTER: A PROSPECTIVE COHORT STUDY
CRITICAL CARE MEDICINE 1
333ASSESSMENT OF QUALITY OF SLEEP IN PATIENTS RECOVERING FROM CRITICAL CARE ILLNESS AND FACTORS AFFECTING IT
AUTHOR INDEX
335AUTHOR INDEX

Index

2024 MayVol. 29 Issue 5
2024 AprVol. 29 Issue 4
2024 MarVol. 29 Issue 3
2023 MarVol. 29 Supplement 1
ANZSRS/TSANZ Annual Scientific Meeting 2024
2024 FebVol. 29 Issue 2
2024 JanVol. 29 Issue 1
2023 DecVol. 28 Issue 12
2023 NovVol. 28 Issue 11
2023 NovVol. 28 Supplement 4
APSR 2023 Congress Abstracts
2023 OctVol. 28 Issue 10
2023 SepVol. 28 Issue 9
2023 AugVol. 28 Issue 8
2023 JulVol. 28 Issue 7
2023 JunVol. 28 Issue 6
2023 MayVol. 28 Issue 5
2023 AprVol. 28 Issue 4
2023 MarVol. 28 Issue 3
2023 MarVol. 28 Supplement 3
Australian Lung Cancer Conference 2023
2023 MarVol. 28 Supplement 2
ANZSRS/TSANZ Annual Scientific Meeting 2023
2023 FebVol. 28 Issue 2
2023 FebVol. 28 Supplement 1
APSR 2022 Congress Abstracts
2023 JanVol. 28 Issue 1
2022 DecVol. 27 Issue 12
2022 NovVol. 27 Issue 11
2022 OctVol. 27 Issue 10
2022 SepWorld Lung Day 2022
2022 SepVol. 27 Issue 9
2022 AugVol. 27 Issue 8
2022 JulVol. 27 Issue 7
2022 JunVol. 27 Issue 6
Special Issue: Occupational Lung Health
2022 MayVol. 27 Issue 5
2022 AprVol. 27 Issue 4
2022 MarVol. 27 Issue 3
2022 MarVol. 27 Issue s1
ANZSRS and TSANZ abstracts
2022 FebVol. 27 Issue 2
2022 JanVol. 27 Issue 1
2021 DecVol. 26 Issue 12
2021 NovVol. 26 Issue 11
2021 NovVol. 26 Supplement 3
APSR Congress Abstracts
2021 OctVol. 26 Issue 10
2021 SepVol. 26 Issue 9
2021 AugVol. 26 Issue 8
2021 JulVol. 26 Issue 7
2021 JunVol. 26 Issue 6
2021 MayVol. 26 Issue 5
2021 AprVol. 26 Issue 4
2021 AprVol. 26 Issue s2
ANZSRS and TSANZ abstracts
2021 MarVol. 26 Issue 3
2021 FebVol. 26 Issue 2
2021 JanVol. 26 Issue s1
Supplement: APSR Assembly Virtual Meetings
2021 JanVol. 26 Issue 1
2020 DecVol. 25 Issue 12
2020 NovVol. 25 Issue 11
2020 NovVol. 25 Issue s2
Essential update in lung cancer medicine
2020 OctVol. 25 Issue 10
2020 SepVol. 25 Issue 9
Special issue: Interventional Pulmonoogy pearls
2020 AugVol. 25 Issue 8
2020 JulVol. 25 Issue 7
2020 JunVol. 25 Issue 6
2020 JunVol. 25 Supplement 1
ANZSRS and TSANZ abstracts
2020 MayVol. 25 Issue 5
2020 AprVol. 25 Issue 4
2020 MarVol. 25 Issue 3
2020 FebVol. 25 Issue 2
2020 JanVol. 25 Issue 1
2019 DecVol. 24 Issue 12
2019 NovVol. 24 Issue 11
2019 NovVol. 24 Supplement 2
APSR Congress Abstracts
2019 OctVol. 24 Issue 10
2019 SepVol. 24 Issue 9
2019 AugVol. 24 Issue 8
2019 JulVol. 24 Issue 7
2019 JunVol. 24 Issue 6
2019 MayVol. 24 Issue 5
2019 AprVol. 24 Issue 4
2019 MarVol. 24 Issue 3
2019 MarVol. 24 Supplement 1
ANZSRS and TSANZ abstracts
2019 FebVol. 24 Issue 2
2019 JanVol. 24 Issue 1
2018 DecVol. 23 Issue 12
2018 NovVol. 23 Supplement 2
APSR Congress Abstracts
2018 NovVol. 23 Issue 11
2018 OctVol. 23 Issue 10
2018 SepVol. 23 Issue 9
2018 AugVol. 23 Issue 8
2018 JulVol. 23 Issue 7
2018 JunVol. 23 Issue 6
2018 MayVol. 23 Issue 5
2018 AprVol. 23 Issue 4
2018 MarVol. 23 Supplement 1
ANZSRS and TSANZ abstracts
2018 MarVol. 23 Issue 3
2018 FebVol. 23 Issue 2
2018 JanVol. 23 Issue 1
2017 NovVol. 22 Supplement 3
APSR Congress Abstracts
2017 NovVol. 22 Issue 8
2017 OctVol. 22 Issue 7
2017 AugVol. 22 Issue 6
2017 JulyVol. 22 Issue 5
2017 MayVol. 22 Issue 4
2017 AprVol. 22 Issue 3
2017 MarVol. 22 Supplement 2
ANZSRS and TSANZ abstracts
2017 MarVol. 22 Supplement 1
Airway Vista abstracts
2017 FebVol. 22 Issue 2
2017 JanVol. 22 Issue 1
2016 NovVol. 21 Supplement 3
APSR Congress Abstracts
2016 NovVol. 21 Issue 8
2016 OctVol. 21 Issue 7
2016 AugVol. 21 Issue 6
2016 JulVol. 21 Issue 5
2016 MayVol. 21 Issue 4
2016 AprVol. 21 Supplement 2
ANZSRS and TSANZ abstracts
2016 AprVol. 21 Issue 3
2016 MarVol. 21 Supplement 1
Airway Vista abstracts
2016 FebVol. 21 Issue 2
2016 JanVol. 21 Issue 1
2015 DecVol. 20 Supplement 3
APSR Congress Abstracts
2015 NovVol. 20 Issue 8
2015 OctVol. 20 Issue 7
2015 AugVol. 20 Issue 6
2015 JulVol. 20 Issue 5
2015 MayVol. 20 Issue 4
2015 AprVol. 20 Issue 3
2015 MarVol. 20 Supplement 2
ANZSRS and TSANZ abstracts
2015 MarVol. 20 Supplement 1
Airway Vista abstracts
2015 FebVol. 20 Issue 2
2015 JanVol. 20 Issue 1
2014 NovVol. 19 Issue 8
2014 NovVol. 19 Supplement 3
APSR Congress Abstracts
2014 OctVol. 19 Issue 7
2014 AugVol. 19 Issue 6
2014 JulVol. 19 Issue 5
2014 MayVol. 19 Issue 4
2014 AprVol. 19 Issue 3
2014 AprVol. 19 Supplement 2
ANZSRS and TSANZ abstracts
2014 MarVol. 19 Supplement 1
Airway Inflammation
2014 FebVol. 19 Issue 2
2014 JanVol. 19 Issue 1
2013 NovVol. 18 Issue 8
2013 OctVol. 18 Supplement 4
APSR Congress Abstracts
2013 NovVol. 18 Supplement 3
Airway Inflammation
2013 OctVol. 18 Issue 7
2013 AugVol. 18 Issue 6
2013 JulVol. 18 Issue 5
2013 MayVol. 18 Issue 4
2013 AprVol. 18 Issue 3
2013 AprVol. 18 Supplement 2
ANZSRS and TSANZ abstracts
2013 AprVol. 18 Supplement 1
Airway Vista abstracts
2013 FebVol. 18 Issue 2
2013 JanVol. 18 Issue 1
2012 DecVol. 17 Supplement 2
APSR Congress Abstracts
2012 NovVol. 17 Issue 8
2012 OctVol. 17 Issue 7
2012 AugVol. 17 Issue 6
2012 JulVol. 17 Issue 5
2012 MayVol. 17 Issue 4
2012 AprVol. 17 Issue 3
2012 AprVol. 17 Supplement 1
ANZSRS and TSANZ abstracts
2012 FebVol. 17 Issue 2
2012 JanVol. 17 Issue 1
2011 NovVol. 16 Issue 8
2011 NovVol. 16 Supplement 2
APSR Congress Abstracts
2011 OctVol. 16 Issue 7
2011 AugVol. 16 Issue 6
2011 JulVol. 16 Issue 5
2011 MayVol. 16 Issue 4
2011 AprVol. 16 Issue 3
2011 AprVol. 16 Supplement 1
ANZSRS and TSANZ abstracts
2011 FebVol. 16 Issue 2
2011 JanVol. 16 Issue 1
2010 NovVol. 15 Supplement 2
APSR Congress Abstracts
2010 NovVol. 15 Issue 8
2010 OctVol. 15 Issue 7
2010 AugVol. 15 Issue 6
2010 JulVol. 15 Issue 5
2010 MayVol. 15 Issue 4
2010 AprVol. 15 Issue 3
2010 MarVol. 15 Supplement 1
ANZSRS and TSANZ abstracts
2010 FebVol. 15 Issue 2
2010 JanVol. 15 Issue 1
2009 NovVol. 14 Issue 8
2009 NovVol. 14 Supplement 3
APSR Congress Abstracts
2009 OctVol. 14 Supplement 2
Guidelines: Hospital-Acquired Pneumonia
2009 SepVol. 14 Issue 7
2009 Vol. 14 Issue 6
2009 JulVol. 14 Issue 5
2009 MayVol. 14 Issue 4
2009 AprVol. 14 Issue 3
2009 AprVol. 14 Supplement 1
ANZSRS and TSANZ abstracts
2009 MarVol. 14 Issue 2
2009 JanVol. 14 Issue 1
2008 NovVol. 13 Issue 7
2008 NovVol. 13 Supplement 5
APSR Congress Abstracts
2008 NovVol. 13 Supplement 4
Lung Disease
2008 SepVol. 13 Issue 6
2008 SepVol. 13 Supplement 3
ESAP: TB
2008 JulVol. 13 Issue 5
2008 JunVol. 13 Issue 4
2008 MayVol. 13 Issue 3
2008 AprVol. 13 Supplement 2
ANZSRS and TSANZ Abstracts
2008 MarVol. 13 Supplement 1
ESAP Abstracts
2008 MarVol. 13 Issue 2
2008 JanVol. 13 Issue 1
2007 NovVol. 12 Supplement 4
APSR Congress Abstracts
2007 NovVol. 12 Supplement 3
Asthma
2007 NovVol. 12 Issue 6
2007 SepVol. 12 Issue 5
2007 JulVol. 12 Issue 4
2007 MayVol. 12 Supplement 2
ESAP Abstracts
2007 MayVol. 12 Issue 3
2007 MarVol. 12 Supplement 1
ANZSRS and TSANZ Abstracts
2007 MarVol. 12 Issue 2
2007 JanVol. 12 Issue 1
2006 NovVol. 11 Supplement 5
APSR Congress Abstracts
2006 NovVol. 11 Issue 6
2006 SepVol. 11 Supplement 4
Guidelines: Cough
2006 SepVol. 11 Supplement 3
Guidelines: Respiratory Infections
2006 SepVol. 11 Issue 5
2006 JulVol. 11 Issue 4
2006 MayVol. 11 Issue 3
2006 MarVol. 11 Supplement 2
ANZSRS and TSANZ abstracts
2006 MarVol. 11 Issue 2
2006 JanVol. 11 Supplement 1
Surfactant Molecular Pathophysiology
2006 JanVol. 11 Issue 1
2005 NovVol. 10 Supplement 3
APSR Congress Abstracts
2005 NovVol. 10 Supplement 2
Respiratory function tests
2005 NovVol. 10 Issue 5
2005 SepVol. 10 Issue 4
2005 JunVol. 10 Issue 3
2005 MarVol. 10 Supplement 1
ANZSRS and TSANZ abstracts
2005 MarVol. 10 Issue 2
2005 JanVol. 10 Issue 1
2004 DecVol. 9 Supplement 3
APSR Congress Abstracts
2004 NovVol. 9 Issue 4
2004 AugVol. 9 Issue 3
2004 JunVol. 9 Issue 2
2004 MarVol. 9 Supplement 2
APSR Congress Abstracts
2004 MarVol. 9 Supplement 1
Guidelines: Hospital-Acquired Pneumonia
2004 MarVol. 9 Issue 1
2003 DecVol. 8 Issue 4
2003 NovVol. 8 Supplement 1
SARS
2003 SepVol. 8 Issue 3
2003 JunVol. 8 Issue 2
2003 AprVol. 8 Supplement 2
APSR Congress Abstracts
2003 MarVol. 8 Issue 1
2002 DecVol. 7 Issue 4
2002 SepVol. 7 Issue 3
2002 JunVol. 7 Issue 2
2002 MarVol. 7 Supplement 1
APSR Congress Abstracts
2002 MarVol. 7 Issue 1
2001 DecVol. 6 Issue 4
2001 SepVol. 6 Issue 3
2001 JunVol. 6 Supplement 2
Chronic Obstructive Lung Diseases
2001 JunVol. 6 Issue 2
2001 MarVol. 6 Issue 1
2000 DecVol. 5 Issue 4
2000 SepVol. 5 Issue 3
2000 JunVol. 5 Issue 2
2000 JunVol. 05 Supplement 2
TSANZ abstracts
2000 AprVol. 05 Supplement 1
TSANZ abstracts
2000 MarVol. 5 Issue 1
1999 DecVol. 4 Issue 4
1999 SepVol. 4 Issue 3
1999 JunVol. 4 Issue 2
1999 AprVol. 04 Supplement 1
TSANZ abstracts
1999 JanVol. 4 Issue 1
1998 DecVol. 3 Issue 4
1998 SepVol. 3 Issue 3
1998 JunVol. 3 Issue 2
1998 MarVol. 3 Issue 1
1997 DecVol. 2 Issue 4
1997 SepVol. 2 Issue 3
1997 JunVol. 2 Issue 2
1997 MarVol. 2 Issue 1
1996 DecVol. 1 Issue 4
1996 SepVol. 1 Issue 3
1996 JunVol. 1 Issue 2
1996 MarVol. 1 Issue 1